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ABSTRACT 
The Notch receptor is an evolutionarily highly conserved transmembrane 
protein essential to a wide spectrum of cellular systems. Notch is especially 
important to T-cell development, and its deregulation leads to leukemia. Although 
not well characterized, Notch signaling continues to play an integral role in 
peripheral T-cells, in which a unique mode of Notch activation can occur. In 
contrast to canonical Notch activation initiated by adjacent ligand-expressing 
cells, T-cell receptor (TCR)-stimulation is sufficient to induce robust Notch 
signaling. However, the interactions between these two pathways have not been 
defined.   
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In this dissertation, we show that Notch activation occurs in peripheral T-
cells within a few hours post TCR-stimulation and is required for optimal T-cell 
activation. Utilizing a panel of inhibitors against components of the TCR signaling 
cascade, we demonstrate that Notch activation is facilitated through initiation of 
protein kinase C-induced ADAM-metalloprotease activity. Moreover, 
internalization of Notch via endocytosis is indispensible for this process. Whereas 
ligand-mediated Notch stimulation relies on mechanical pulling forces that disrupt 
the autoinhibitory domain of Notch, we hypothesized that in T-cells in the 
absence of ligands, these conformational changes are induced through chemical 
adjustments in the endosome, causing alleviation of autoinhibition and receptor 
activation. Our data show that endocytosis is not only a prerequisite for TCR-
induced Notch processing during normal T-cell function, but is essential even in 
Notch-mutated T-leukemia cells exhibiting constitutively active Notch signaling.    
Our work has also focused on signaling mechanisms of Notch following 
receptor activation. The Notch signal is transduced via cleavage of the 
intracellular portion of the receptor that subsequently translocates to the nucleus 
where it regulates gene transcription via interactions with its DNA-binding 
partner, RBPJκ. Utilizing RBPJκ-deficient T-cells, we show that, although Notch 
signaling is required, RBPJκ-dependent signaling is dispensable for peripheral T-
cell proliferation and activation. Using retroviral constructs that encode modified, 
active forms of Notch restricted to the nucleus or cytoplasm, we provide evidence 
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that Notch signaling may utilize RBPJκ-independent pathways for signal 
transduction.  
In conclusion, T-cells have evolved a unique method of Notch receptor 
activation, described for the first time in this dissertation, as well as novel 
mechanisms that facilitate downstream signaling. 
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1 INTRODUCTION 
Notch signaling is unique in that the Notch protein functions as both a 
plasma-membrane receptor and a nuclear transcription factor. Signals are 
induced by contact with adjacent cells that express membrane-bound ligands. 
Upon ligation, the receptor is cleaved and releases an intracellular fragment of 
Notch (ICN), which translocates to the nucleus where it regulates gene 
transcription. This signaling pathway is evolutionarily highly conserved and is not 
only expressed in nearly all metazoans from Drosophila melanogaster to 
mammals (Gazave et al. 2009), but performs vital functions in an extraordinarily 
broad range of cell types within each organism (Andersson et al. 2011). In fact, in 
Drosophila, Notch influences the development of nearly every tissue (Artavanis-
Tsakonas et al. 1999). 
Originally, Notch was discovered in Drosophila and received its name from 
mutations in this gene resulting in a notched wing phenotype (Morgan 1917; 
Mohr 1919). Almost three quarters of a century later, a Notch ortholog was 
discovered in human patients suffering from T-cell Acute Lymphoblastic 
Leukemia (T-ALL) caused by mutations in this protein (Ellisen et al. 1991). Today 
we know that Notch regulates a wide spectrum of cellular responses, which 
include, among others, cell lineage specification, stem cell maintenance, cell 
proliferation and apoptosis (Deftos et al. 1998; Rangarajan et al. 2001; Jundt 
2002; Weng et al. 2003; Sade et al. 2004; Liu et al. 2010; Andersson et al. 2011). 
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Notch plays an especially important role in T-cell development (Allman et al. 
2002; Radtke et al. 2002) and its deregulation inevitably leads to T-ALL in mice 
and humans (Ellisen et al. 1991; Pear et al. 1996). Depending on the tissue type, 
Notch has been described as a tumor suppressor in myeloid cells, as well as an 
oncogene in the lymphoid compartment (Radtke and Raj 2003; Lobry et al. 
2014). Therefore, overall, the outcome of the transduced Notch signal is highly 
dependent on the cellular context in which it is received. 
 
1.1 Notch Determines Cell Fates during Development 
A major role of Notch is to initiate differential development in adjacent 
progenitor cells, which ultimately results in complex structures and organs that 
are composed of distinct and specifically arranged cell types. The Notch receptor 
is involved in two general differentiation processes known as lateral inhibition and 
lateral induction (Figure 1; reviewed by Lai 2004).  
During lateral inhibition, Notch initiates divergent developmental pathways 
in adjacent equipotent cells. This leads to primary phenotypes in cells that do not 
receive the Notch signal (Notch ligand expressing cells) and secondary cell fates 
in cells that do receive the Notch signal (Notch receptor expressing cells), since 
Notch signaling inhibits the primary phenotype (Kopan and Turner 1996). The 
decision to commit to each fate is made by stochastic, subtle differences in the 
quantities of Notch receptors and ligands expressed on these otherwise 
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equivalent cells. Through the process of lateral inhibition these minute variations 
gradually result in cells exclusively expressing either Notch receptors or ligands. 
This in turn determines unique gene expression profiles in signal-sending versus 
signal-receiving cells (Kopan and Turner 1996). Thus, the number of cells that 
will assume the primary phenotype is restricted by short-range Notch signals that 
originate from each cell’s immediate surroundings. A classic example can be 
seen in the developing nervous system of Drosophila where Notch ligand 
induced signaling prevents some Notch expressing cells within proneural clusters 
from differentiating into the neural (primary) phenotype, and instead causes them 
to differentiate into an epidermal phenotype by negatively regulating proneural 
genes. Experimentally, this was shown when overexpression of activated Notch 
(ICN) in this system caused all proneural cluster cells to differentiate into 
epidermal cells and eliminated the neural phenotype (i.e. sensory bristles) in 
adult flies (Parks et al. 1997).  
Moreover, Notch signaling uses lateral inhibition for maintenance of stem 
cell populations. Asymmetrical divisions lead to daughter cells that inherit 
differing quantities of Notch receptors. This uneven distribution initiates the 
process of lateral inhibition and forces the Notch expressing cell to remain in an 
undifferentiated state, whereas the other daughter cell is allowed to mature 
uninhibited. For instance, asymmetrical divisions of radial glial cells in the 
cerebral cortex cause Notch receptors to be restricted to only the basal daughter  
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Figure 1 – Lateral Inhibition & Lateral Induction 
In lateral inhibition, adjacent equipotent cells assume opposing cell fates, 
depending on their relative expression of Notch receptor or Notch ligands. In 
lateral induction non-equivalent cells are induced into a specific cell type 
(adapted from Lai 2004). Grey cells - undifferentiated; orange cells - primary 
phenotype; green cells - secondary phenotype.  
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cell, whereas the E3 ubiquitin-protein ligase mindbomb, which is necessary for 
Notch ligand function (Itoh et al. 2003), is segregated into the apical daughter cell 
(Dong et al. 2012). This imbalance results in differentiating apical cells and self-
renewing basal cells high in Notch expression.   
Conversely, lateral induction promotes the differentiation of a specific cell 
type among non-equivalent cells. This is most prominent in the generation of 
tissue boundaries such as in arterial vessel formation. In this case, Notch on 
progenitor cells is activated by ligands on the vascular endothelium, which results 
in the generation of a smooth muscle layer around the vessel (Manderfield et al. 
2012). Another example of lateral induction can be seen in the development of T-
lymphocytes in the thymus as discussed in the next section.  
 
1.2 Notch in Lymphocyte Development and Maturation 
T-cell development is strongly influenced by Notch-mediated signals (Figure 
2). The earliest lymphocyte progenitors that migrate to the thymus are provided 
with Notch ligands by the thymic microenvironment, initiating the T-cell program 
while preventing the B-cell fate. This was shown in experiments where bone 
marrow precursors were transduced with constitutively active Notch1 and 
transplanted into irradiated wild-type mice (Pui et al. 1999). Under normal 
conditions, T-cells only mature in the thymus, whereas B-cells mature in the bone 
marrow. In this experiment, however, T-cells were developing extrathymically in 
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the bone marrow, whereas B-cell development was completely abrogated. 
Conversely, when Notch1 was deleted in bone marrow precursor cells, even the 
earliest T-cell progenitor cells failed to develop and B-cells could be observed in 
the thymus (Radtke et al. 1999). These data suggest that Notch directs lymphoid 
progenitors to the T-cell lineage by suppressing B-cell differentiation.  
Notch is also important in subsequent T-cell fate decisions (reviewed by 
Deftos and Bevan 2000). After progenitor cells have committed to the T-cell 
lineage, double-negative (CD4-CD8-) thymocytes, the earliest identified T-cell 
precursors, need to commit to either the αβ or γδ lineage. A model was 
proposed, in which Notch signals synergize with T-cell receptor (TCR) signaling 
to induce αβ T-cell development (Washburn et al. 1997). When transduced with 
constitutively active Notch1, even cells that have a defective TCRβ chain or 
productively rearranged γ and δ chain genes, develop into the αβ lineage. These 
findings were corroborated by observations that decreases in Notch signal favor 
the γδ over the αβ linage, suggesting that γδ-T-cell development is independent 
of Notch (Tanigaki et al. 2004; Ciofani et al. 2006; Garbe et al. 2006). 
Having passed through the double-negative developmental phase, the αβ 
T-cell makes yet another cell fate decision at the double-positive (CD4+CD8+) 
stage. Whether the newly rearranged αβTCR recognizes major histocompatibility 
complex class I (MHCI) or MHCII molecules on thymic cortical epithelial cells 
determines if they differentiate into single-positive CD8 or CD4 expressing T-
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cells, respectively. While Notch signaling has also been suggested to be involved 
in this process, this is highly controversial. In one gain-of-function study, 
thymocytes that express a constitutively active form of Notch1 were driven 
towards CD8+ over CD4+ development (Robey et al. 1996). Contradicting these 
results are experiments utilizing a loss-of-function approach, where T-cells that 
are Notch1 deficient, have no such defect (Wolfer et al. 2001). This discrepancy 
between gain-of-function and loss-of-function studies continues when looking at 
processes downstream of Notch signaling. While it has been proposed that 
Hes1, a Notch target gene (NTG), is able to silence cd4 expression in 
thymocytes (Kim and Siu 1998), deletion of Hes1 has no effect on CD4/CD8 cell 
fate decisions (Kaneta et al. 2000). Therefore, it is possible that rather than 
influencing cell fate decisions at this stage, Notch stimulates both CD4+ and 
CD8+ T-cell survival and proliferation, whereas lineage decisions are solely made 
by TCR-MHC interactions.  
One further checkpoint in the maturation of T-cells is the differentiation of 
naïve peripheral CD4+ T-cells into effector cell types such as T-helper 1 (TH1) 
and TH2 cells. While the main instructive signals for differentiation of naïve T-cells 
come from antigen presenting cells (APCs) that have ingested and processed 
foreign antigens and produce cytokines and co-activation signals in response to 
these molecules, a critical role has also been suggested for Notch in affecting 
cell fate decisions at this stage. Nonetheless, its involvement at this juncture of T-
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cell differentiation is not well understood, with different experimental approaches 
leading to contradictory results.  
On one side of the argument, Notch involvement has been demonstrated in 
the differentiation of TH1 cells, which are the host’s defense against intracellular 
microbes. TH1 cells are generated in response to interleukin-12 (IL-12) produced 
mainly by dendritic cells and macrophages. They are characterized by their 
production of the cytokine interferon-γ (IFNγ) and expression of the master 
transcription factor T-bet. Notch signaling, induced by ligand-expressing APCs, 
can lead to an increase in both of these hallmark proteins in T-cells that are 
stimulated in TH1-polarizing conditions (in the presence of IL-12 and anti-IL-4; 
Maekawa et al. 2003). At the same time Notch signaling is able to inhibit the 
differentiation of TH2 cells, which are an alternative effector T-cell triggered by IL-
4 in response to extracellular pathogens and allergens. These cells are 
characterized by the expression of the master regulator GATA-3 and their 
secretion of IL-4. In TH2-polarizing conditions (in the presence of IL-4 and anti-IL-
12), ligand-induced Notch signaling reduces the concentration of IL-4 production 
(Maekawa et al. 2003). Moreover, T-cells stimulated under TH1 conditions and 
treated with γ-Secretase inhibitor (GSI), a pharmacological inhibitor of Notch 
signaling, failed to upregulate T-bet, suggesting that Notch is important in 
activating gene programs that facilitate TH1 differentiation (Minter et al. 2005).  
9 
 
In contrast, Notch was also shown to induce TH2 fates through the 
promotion of IL-4 and GATA-3 expression as demonstrated in T-cells with 
defective canonical Notch signaling, which blocked TH2 differentiation (Amsen et 
al. 2004; Tanaka et al. 2006; Fang et al. 2007). In light of these disparate results, 
it has been proposed that the choice between TH1 or TH2 differentiation depends 
on which Notch ligand engages the receptor (Amsen et al. 2004), although this 
phenomenon has not been further investigated and is controversial. Yet, other 
studies suggest that Notch is not involved in effector T-cell differentiation at all, 
as Notch1-deficient CD4+ cells do not exhibit defects in either TH1 or TH2 cell 
generation (Tacchini-Cottier et al. 2004). It has also been propose that instead of 
directing differentiation, Notch signal only augments cytokine production in cells 
that have already been primed to mature into a specific effector cell type (Ong et 
al. 2008). Lastly, it has been suggested that Notch does not direct TH-cell 
differentiation, nor do cytokines influence Notch activity. Instead, Notch regulates 
TH1 and TH2 genetic programs independently of cytokines by enhancing all 
possible responses simultaneously via sensitization of target genes to activating 
signals (Bailis et al. 2013). 
To further complicate this matter, Notch signaling has also been proposed 
to regulate differentiation of other CD4+ T-cell subsets including TH9, TH17, TH22, 
T-follicular helper cells (TFH), and induced T-regulatory cells (iTREG), as well as 
facilitate differentiation of CD8+ T-cells into terminal effector cells versus memory 
cells (Amsen et al. 2015). Consequently, there are many outstanding questions  
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Figure 2 – Involvement of Notch in T-cell Development 
Notch plays a critical role in multiple differentiation decisions throughout the life-
span of T-cells. This involvement starts in the earliest T-cell progenitor cells, 
continues during thymocyte development and is still relevant in maturation steps 
in the periphery. DN, double negative; DP, double positive; ETP, early T-cell 
precursor; TH, T-helper cell; TREG, T-regulatory cell; TCR, T-cell receptor. 
11 
 
as to what exact role Notch plays in the differentiation of mature peripheral T-
cells.  
 
1.3 Notch in Leukemogenesis 
A signaling pathway that is involved in so many aspects of development 
and homeostasis cell populations can also easily result in malignancies if not 
properly regulated. Therefore it is not surprising that Notch has been implicated 
in tumorigenesis since its discovery in humans, when its involvement in the 
(7;9)(q34;q34.3) chromosomal translocation in a small group of T-ALL cases was 
revealed (Ellisen et al. 1991). This mutation generates constitutively active 
Notch1, whose expression is driven by the TCRβ locus. Since then, various 
Notch gain-of-function mutations have been described in more than 60% of T-
ALL patients, making this an important mutation in T-ALL pathogenesis (Weng et 
al. 2004). Selective pressure for Notch mutations in lymphocytes seems to be 
specific to cancers of the T-cell lineage. They are never found in B-ALL and can 
only rarely be seen in acute myelogenous leukemias that are poorly differentiated 
and express T-cell markers (Weng et al. 2004; Palomero et al. 2006). This can 
possibly be explained by the vast involvement of Notch in T-cell development as 
described in the previous section. In mice, genetic alterations that produce 
constitutively active forms of Notch have similar consequences and culminate in 
T-cell leukemia (Pear et al. 1996). Moreover, leukemia can be prevented entirely 
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in mice with Rag-/- or pre-T-cell receptor α (pTα)-/- backgrounds, which block TCR 
chain rearrangement and pre-TCR expression, respectively, and thus eliminate 
TCR signaling (Allman et al. 2001; Bellavia et al. 2002). This suggests that there 
is a link between TCR signaling and Notch-associated leukemogenesis.  
Notch1 mutations are generally located in two hotspots and are present in 
the majority of Notch-induced T-ALL (Figure 3B, Weng et al. 2004). The most 
common mutations are located in exons 26 and 27, which code for the 
heterodimerization domain (HD), a region that is essential in the regulation of 
Notch activity as discussed in the next section. These mutations destabilize the 
HD domain and result in the loss of autoinhibition (Malecki et al. 2006). 
Consequently, the receptor is activated independently of ligand, which allows 
constitutive Notch signaling. The other hotspot is located in exon 34, which codes 
for the PEST domain [rich in proline (P), glutamic acid (E), serine (S) and 
threonine (T)]. Mutations in this exon generally cause truncations most commonly 
by generating premature stop codons resulting in deletion of the domain (Chiang 
et al. 2006). The PEST domain is essential in degradation of the activated Notch 
protein, and its deletion results in an extended signaling half-life. These two 
hotspots are not only found in 40% and 30% of all human T-ALL, respectively, 
but appear in almost all murine models of acute T-cell leukemias. The high 
frequency and oncogenicity of Notch mutations have positioned Notch signaling 
in the front rows of T-ALL research.   
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Figure 3 – Notch Receptors and Ligands 
A) Structure of Notch receptors on signal-receiving cells and Notch ligands on 
signal-sending cells. In humans and mice there are four Notch receptors, and five 
Notch ligands within two families, the Jagged and the Delta-like family. B) 
Locations of the three cleavage sites on the Notch receptor (S1-3), and mutation 
hotspot regions in the HD and PEST domains ( ). NRR – negative regulatory 
region. 
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1.4 The Notch Receptor Family and Its Ligands 
The Notch family of type-1 transmembrane receptors consists of four 
protein paralogues (Notch1-4) in humans and mice, with mostly non-redundant 
functions (Figure 3A). Notch1 and 3 are most highly expressed on T-cells (Felli et 
al. 1999), whereas Notch2 signaling is important to mature B-cells, especially the 
marginal zone subset (Saito et al. 2003). In contrast, Notch4 is not expressed on 
leukocytes, but on other tissues such as vascular endothelium (Carlson et al. 
2005).  
Before integration into the plasma membrane, the Notch receptor is post-
translationally cleaved at the S1 site, which is located 70 amino acids (aa) N-
terminal of the transmembrane domain (Figure 3B). This cleavage occurs inside 
the trans-Golgi network by a furin-like protease, resulting in a non-covalently 
joined heterodimer that is held together by Ca2+-dependent ionic bonds (Logeat 
et al. 1998; Rand et al. 2000). The two polypeptides that constitute the mature 
membrane-bound form of Notch are the extracellular domain (ECD) and the 
transmembrane fragment (TMF; Figure 3). The TMF is comprised of a small 
70aa extracellular portion, the transmembrane domain and an intracellular 
domain. Starting at the N-terminus, the ECD consists of 29 to 36 epidermal 
growth factor (EGF)-like domains, of which some are calcium-binding (cbEGF). 
cbEGF12 (as counted from the N-terminus) seems to be the main binding 
domain involved in receptor-ligand interactions; however, additional EGF sites 
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may contribute to increase binding stability (Rebay et al. 1993; Hambleton et al. 
2004).  
Following the EGF-like domains is the negative regulatory region (NRR), 
which encompasses three Lin12-Notch repeats (LNR) and the HD domain that 
results from S1 cleavage and connects the two heterodimer fragments (Logeat et 
al. 1998). The NRR is crucial in preventing Notch activation in the absence of the 
correct signal (Gordon et al. 2009). Upon receptor-ligand interaction, 
conformational changes in the NRR allow access by ADAM metalloproteases to 
the S2 site (discussed in chapter 1.5). This site is located 12aa away from the 
membrane in the extracellular region of the TMF and is usually masked by the 
LNR (Figure 3B; Sanchez-Irizarry et al. 2004). The secondary structure of the 
LNR, necessary to conceal the S2 cleavage site, is held into place by calcium-
dependent ionic bonds, and removal of calcium by EDTA-mediated chelation 
leads to ligand-independent receptor activation (Rand et al. 2000). Many forms of 
Notch-induced leukemias have mutations in the HD domain that either elongate 
the sequence between the S2 site and the LNR, or destabilize the region via 
point mutations, small insertion or short deletions (Figure 3B). These prevent the 
NRR from auto-inhibiting Notch activation, which ultimately leads to unregulated 
Notch signaling (Malecki et al. 2006). 
On the TMF, C-terminal of the fragment-spanning HD domain is the 
transmembrane domain. It contains the S3 cleavage site, which is a substrate for 
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regulated intramembrane proteolysis (RIP) by the γ-Secretase (γSec) complex 
(Brown et al. 2000). This event will only occur after the rate-limiting S2 cleavage 
has taken place, making S3 accessible to γSec (Figure 3B; Struhl and Adachi 
2000). S3 proteolysis results in the release of the Notch intracellular domain – 
now called ICN – from the membrane and allows Notch signaling to be initiated. 
ICN consists of an N-terminal RBPJ-associated molecule (RAM) domain that 
enables Notch to bind to its DNA-binding partner “Recombination signal Binding 
Protein for immunoglobulin kappa J region” (RBP-Jκ or simply RBPJ, Lubman et 
al. 2007). The RAM domain is followed by 1) a nuclear localization sequence 
(NLS) that causes transmigration of ICN into the nucleus; 2) seven ankyrin 
repeats (ANK) that are involved in binding of the transcription co-factor 
Mastermind-like (MAML, Nam et al. 2006) and to lesser extent RBPJ (Tani et al. 
2001); 3) a second NLS sequence; 4) a transcriptional activation domain (TAD), 
which is important in recruiting histone acetyltransferases (HAT), and 
consequently chromatin remodeling complexes to make NTGs accessible for 
activation (Kurooka and Honjo 2000); and 5) a C-terminal PEST domain, which 
allows ICN to be marked for degradation via the proteasome (Fryer et al. 2004).  
Canonical Notch ligands of the Delta/Serrate/Lag-2 (DSL) family in humans 
and mice fall into one of two classes, depending on whether they are a 
homologue of the Drosophila Notch ligand Delta or Serrate (Figure 3A). The 
Delta-like proteins include Delta-Like 1 (DLL1), DLL3, DLL4 and the Serrate 
homologues are comprised of Jagged1 (Jag1) and Jag2. Both families are similar 
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in structure and contain a Module at the N-terminus of Notch Ligands (MNNL) 
domain and a DSL domain that both seem to participate in optimal binding to 
Notch (Parks et al. 2006). C-terminal of the DSL domain, the Jagged and DLL-
family ligands contain 16 and 5-9 EGF repeats, respectively. A distinguishing 
factor between the Jag and DLL families is the juxtamembrane cysteine rich 
domain (CRD), which is only present in Jag1 and Jag2. Even though functional 
differences have been ascribed to the four Notch receptors, ligation with either 
DLL or Jagged family ligands leads to the activation of the same canonical 
signaling pathway (Kopan and Ilagan 2009). 
 
1.5 Processing of Ligand-Bound Notch Receptor 
The mechanism of Notch activation that has been studied most thoroughly 
is initiated by the canonical ligands described above. Since Notch activation is 
auto-inhibited through its NRR domain (Gordon et al. 2009), which masks the S2 
site and prevents ADAM-mediated cleavage, conformational changes in the 
receptor need to take place before Notch can become processed. In the 
secondary structure of the rod-shaped Notch receptor, the NRR and the ligand-
binding EGF domains are spatially far apart from each other. Therefore, it is 
unlikely that allosteric regulation of the receptor could produce the necessary 
conformational changes in the heavily folded NRR region to initiate Notch 
signaling. Instead, receptor engagement stimulates a pulling force that results 
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from trans-endocytosis of the ECD into the ligand-expressing cell (Parks et al. 
2000; Nichols et al. 2007).   
Using Drosophila imaginal disc and retinal cells with defective dynamin 
function, important for endocytic vesicle formation, it was shown that Notch 
activation is dependent on ECD dissociation from the receptor and trans-
endocytosis into the ligand-expressing cells (Parks et al. 2000). It has been 
proposed that the pulling force causes conformational changes in the NRR 
region, which consequently allows S2 cleavage to occur, after which the ECD is 
free to be trans-endocytosed. A study in murine C2C12 cells agrees with the 
requirement of Notch ECD trans-endocytosis and substantiates that ligand 
binding alone is insufficient to activate Notch (Nichols et al. 2007). However, this 
study also proposes that ECD dissociation occurs even in the presence of ADAM 
inhibitors. This suggests that dissociation is not a consequence of S2 site 
cleavage, but that the reverse is true, and S2 site exposure to ADAM cleavage is 
the result of ECD dissociation via trans-endocytosis. 
The notion that mechanical pulling forces are involved in Notch activation is 
supported by data indicating that the adhesion forces between Notch and Delta 
are in the nanoNewton (nN) range (Ahimou et al. 2004). This is remarkably 
strong for receptor/ligand interactions. In contrast, the unfolding of the NRR only 
requires forces on the pN scale (Wang and Ha 2013), thus making the pulling 
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force model plausible. Overall, the data suggest that ligand-mediated trans-
endocytosis of the Notch ECD is a prerequisite for further Notch processing. 
Once the S2 site has been exposed – whether by unfolding of the NRR or 
removal of the ECD – further processing is facilitated by ADAM 
metalloproteases. In Drosophila, ADAM10/Kuz has been shown to activate Notch 
receptors. This was demonstrated using dominant negative ADAM10 flies (Duojia 
and Rubin 1997), ADAM10-deficient flies (Sotillos et al. 1997), and RNA 
interference (RNAi) of ADAM10 (Lieber et al. 2002), all of which inhibited Notch 
processing and activity. Furthermore, physical contact between Notch and 
ADAM10 was shown by co-immunoprecipitation (Lieber et al. 2002). 
In addition to ADAM10, in mammalian cells ADAM17/TACE can process 
Notch as well (Brou et al. 2000; Mumm et al. 2000). However, ADAM10 and 
ADAM17 are involved in Notch processing differentially. Using multiple 
approaches of Notch activation in either ADAM10- or ADAM17-defective cells, it 
was shown that ADAM10 is absolutely required for Notch processing upon ligand 
engagement in mammalian cells (Bozkulak and Weinmaster 2009). ADAM17 
was not able to rescue the ADAM10-deficient phenotype, and dominant negative 
ADAM17 expression did not inhibit ligand-induced Notch processing. In contrast, 
ADAM17 was able to process Notch under conditions of ligand-independent 
activation including EDTA chelation, or when using Notch constructs that harbor 
a mutated NRR domain, which renders them hyperactive due to their ability to be 
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processed independently of ligand. It was also shown that ligand-independent 
Notch variants with HD mutations, which occur in T-ALL, are predominantly 
processed by ADAM17, and to much lesser extent by ADAM10 (Bozkulak and 
Weinmaster 2009). Thus, it was concluded that ADAM17 is necessary for ligand-
independent Notch processing, whereas ADAM10 is responsible for ligand-
induced Notch activation.  
After S2 processing by the ADAM metalloproteases, the final step in 
activating Notch and releasing ICN from the membrane is S3 cleavage mediated 
by γSec. This aspartyl protease is an intramembranously cleaving enzyme 
complex that is comprised of multiple protein subunits including the catalytically 
active subunit presenilin, nicastrin, anterior pharynx defective-1 and presenilin 
enhancer-2. γSec substrates generally need to be primed by ectodomain 
shedding from larger precursor proteins (Struhl and Adachi 2000), such as is the 
case in S2-cleavage of Notch, and α-/β-secretase-mediated cleavage of amyloid 
precursor protein (APP) (Thinakaran and Koo 2008). Shedding of the Notch ECD 
results in a residual ectodomain of 12aa in length (Sanchez-Irizarry et al. 2004) 
and allows γSec substrate recognition via the nicastrin subunit that docks to the 
new N-terminus of Notch (Shah et al. 2005).  
Although it has been suggested that γSec is present at the plasma 
membrane as a fully functional and active complex that can cleave APP and 
Notch (Chyung et al. 2005; Hansson et al. 2005), γSec also localizes to early and 
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late endosomes (Lah and Levey 2000), where it processes p75 neurotrophin 
receptor (Urra et al. 2007), as well as APP (Zhang et al. 2006). γSec can even be 
found in lysosomes, where it experiences enhanced activity because of the low 
pH in the endocytic/lysosomal compartment (Pasternak et al. 2003). 
Furthermore, and in contrast to Chyung et al. (2005), it has been proposed that in 
Drosophila (Vaccari et al. 2008) as well as in mammalian cells (Gupta-Rossi et 
al. 2004) Notch/γSec co-localization to the endocytic compartment is absolutely 
critical to Notch activation. Overall, these data indicate that complete processing 
of Notch may require internalization of the receptor where it then becomes 
cleaved and fully activated in the endosome. The vast majority of data on this 
topic has been obtained from studies in Drosophila and this process is largely 
undefined in mammalian cells.  
A much less well understood mechanism of activation has been observed in 
T-cells. TCR-stimulation, in the absence of Notch ligands, is capable of activating 
Notch (Adler et al. 2003; Palaga et al. 2003). Under these conditions Notch 
processing would occur without the ligand-mediated pulling force. The underlying 
pathway that connects TCR stimulation to ICN generation has not yet been 
characterized and will be the main focus of this thesis. 
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1.6 The Role of Receptor Endocytosis in Notch Activation 
Initially, it was believed that the sole function of endocytosis consisted of 
terminating plasma membrane signals by either sequestering membrane 
receptors from ligand binding, or by internalization and degradation of active 
receptor/ligand complexes (reviewed in Bache et al. 2004). But it is becoming 
increasingly apparent that endocytosis and signaling are intertwined processes 
that can affect each other reciprocally (reviewed in Seto et al. 2002; Sorkin and 
Zastrow 2009). There are multiple mechanisms of endocytosis, but possibly the 
most common and best studied form is clathrin-dependent (Figure 4; reviewed by 
Doherty and McMahon 2009). Clathrin is recruited to the plasma membrane by a 
large variety of adaptor and accessory proteins that in turn adhere to lipid- or 
protein-binding domains at the membrane (Traub 2009). These adaptors cause 
clathrin polymerization into curved lattices called clathrin-coated pits. These pits 
continue to invaginate with the help of bending-proteins, such as epsin (Sen et al. 
2012), and form clathrin-coated vesicles (CCV) that eventually bud from the 
internal leaflet of the membrane. The budding process is facilitated by dynamin, 
which is a GTPase that forms a helical polymer around the neck of the CCV 
(Praefcke and McMahon 2004). Upon dynamin-mediated scission, the fully 
formed vesicle is released into the cytoplasm where it is uncoated and can then 
fuse with other membranes (Trahey and Hay 2010). 
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Figure 4 – Clathrin-mediated Endocytosis 
Adaptor proteins, such as AP-2, interact with lipid- and/or protein-binding 
domains at the plasma membrane and in turn recruit clathrin. Clathrin then 
polymerizes and is bent into curved lattices by proteins such as Epsin, forming 
clathrin coated pits (CCP). These pits continue to invaginate and mature into 
clathrin coated vesicles (CCV) that are eventually pinched off of the membrane 
by dynamin, a GTPase that forms a helical polymer around the neck of the CCV. 
The fully formed CCV is eventually uncoated and fuses with other membranes in 
the cell.  
 
 
 
 
 
24 
 
The requirement for endocytosis of Notch ligands during (and even prior to) 
receptor engagement has been thoroughly studied and is well characterized 
(reviewed in Sala et al. 2012). However, the need for internalization of Notch 
itself on the signal-receiving cell as a prerequisite for signal transduction is less 
well established. Evidence in HeLa cells suggests that Notch endocytosis is not 
necessary for its activation, but instead promotes attenuation of Notch signal by 
reducing its expression on the cell surface (Sorensen and Conner 2010). Notch 
can indeed be marked for degradation via ubiquitination by E3-ligases such as 
AIP4/Itch (Chastagner et al. 2008) or Nedd4 (Sakata et al. 2004). It is then 
endocytosed with the help of Numb that recruits the AP2-clathrin adaptor-
complex (Berdnik et al. 2002). But ubiquitination and endocytosis are by no 
means exclusively linked to the down-regulation of Notch signaling.  
On the contrary, the majority of data in Drosophila suggest that endocytosis 
of the receptor is a crucial component of Notch activation. The first findings 
implicating endocytosis in Notch activation were Drosophila studies using 
dynamin-defective shibire-mutants, in which deletion of dynamin in signal-
receiving cells disrupted Notch signal induction (Seugnet et al. 1997). More 
recently, detailed studies of Notch localization and activity were conducted, in 
which successive steps of the endocytic pathway were selectively blocked in 
Drosophila imaginal discs and oocytes (Vaccari et al. 2008). Deletion of shibire (a 
dynamin ortholog), Ras-related protein 5 (Rab5) and Avalanche [the latter two 
are proteins that regulate entry of cargo into the early endosome (EE)], resulted 
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in Notch accumulation at or just below the plasma membrane and significantly 
reduced Notch signaling as measured by a LacZ reporter assay. However, 
blocking the endocytic pathway at later stages by deleting ‘endosomal sorting 
complexes required for transport proteins’ (ESCRT), which control sorting into 
late endosomes (LE), or Fab1 that is important in (pre)-lysosomal compartments, 
did not attenuate Notch signaling, but instead elevated it (Vaccari et al. 2008). 
This enhanced signaling may be a result of prolonged retention of Notch in an 
environment where it can be processed by γSec.  
Further evidence placing Notch processing in the endosome comes from 
experiments in Drosophila using defective variants of the vacuolar proton pump 
V-ATPase that prevent the acidification of the endosome and attenuate Notch 
activation (Yan et al. 2009; Vaccari et al. 2010). This, together with data showing 
that γSec operates optimally in an acidic environment (Pasternak et al. 2003), 
suggests that Notch is preferentially processed in the endosome by γSec, and 
that internalization does play an important role in Notch activation in Drosophila. 
Moreover, the E3 ubiquitin ligase Deltex is implicated in the regulation of 
Notch endocytic trafficking in ligand-independent receptor activation. This is 
demonstrated in Drosophila experiments with null mutations for Deltex that lead 
to failure of Notch internalization and activation (Yamada et al. 2011), as well as 
overexpression experiments that strongly enhance Notch signaling (Hori et al. 
2004). In a yeast two-hybrid system, Drosophila as well as human Deltex was 
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shown to interact across species with the ANK repeats of Notch via its WWE 
(Trp-Trp-Glu)-domain. Deltex mono-ubiquitinates Notch and stabilizes the 
receptor in the endocytic compartment allowing signal transduction to proceed 
(Diederich et al. 1994; Matsuno et al. 1998). Deltex also forms a complex with 
adaptor protein 3 (AP-3; Boehm and Bonifacino 2002) and “homotypic fusion and 
vacuole protein sorting” (HOPS; Bröcker et al. 2012), both of which deliver Notch 
to the exterior membrane of the multivesicular body (MVB) called the limiting 
membrane (Figure 5). This localization on the exterior membrane places the 
intracellular domain of Notch in the cytosol, where, upon its cleavage to form 
ICN, it can begin signaling (Wilkin et al. 2008). Supporting this model are 
experiments carried out in Drosophila examining the role of ‘Suppressor of 
Deltex’ [Su(dx)], also an E3 ubiquitin ligase, that directly opposes the function of 
Deltex. Su(dx) facilitates Notch incorporation into the membranes of intraluminal 
vesicles located inside the MVB, instead of localization to the limiting membrane, 
and prevents ICN signaling (Figure 5). This results in ICN being spatially 
sequestered from the cytosol and degraded (Wilkin et al. 2008). Interestingly, 
HOPS and AP-3 are not needed in ligand-dependent processing of Notch 
indicating that separate pathways underlie ligand-dependent and ligand-
independent Notch activation (Wilkin et al. 2008).  
Overall, it can be concluded that, at least in some forms of Notch activation, 
endocytosis of the receptor and its shuttling through the endosomal compartment 
are important factors. In the ligand-independent process, Deltex facilitates the 
27 
 
endocytosis of Notch from the plasma membrane and, together with HOPS and 
AP3, protects it from degradation by targeting it to limiting membranes of the 
MVB where it can be processed by γSec allowing release of ICN into the cytosol 
(Figure 5). Although it has been shown in mice that Deltex is not required for 
thymic T-cell development (Lehar and Bevan 2006), ligand-independent TCR-
mediated stimulation of Notch signal may share many of the endocytic 
components described in the abovementioned processes. To this point, these 
pathways of Notch activation have all been characterized in Drosophila and there 
is a lack of studies that elucidate the mechanisms in mammalian cells or, more 
specifically, peripheral T-cells.  
 
1.7 Endogenous Processing of Endocytosed Receptor  
Canonical ligand-mediated Notch activation relies on conformational 
changes in the receptor that are induced by the ligand to initiate signal 
transduction. In ligand-independent Notch activation, these conditions must be 
emulated by another method within the endosomal environment to unmask the 
protected S2/S3 sites for cleavage by γSec and/or ADAM metalloproteases. 
There are three possible scenarios that may contribute to this process (Figure 6; 
Palmer and Deng 2015). Firstly, lysozymes may proteolyze the Notch-ECD that 
extends into the intraluminal space of the MVB, thus removing inhibitory 
sequences that prevent γSec recognition (Figure 6A). Whereas this seems to be  
28 
 
 
 
 
 
 
 
Figure 5 – Drosophila model of Endocytosis in Notch Activation 
(1) Deltex facilitates ligand-independent Notch receptor internalization into 
clathrin-coated vesicles (2) that fuse with Rab5-positive EE. Deletion of Deltex, 
Dynamin or Rab5 results in blocking of the Notch signal, whereas overexpression 
of Rab5 causes an accumulation of Notch in the EE, but does not increase ICN 
production. (3) Deltex forms a complex with AP-3 and HOPS that directs Notch to 
Rab7-positive LEs and (4) targets it to the limiting membrane of the MVB. (5) 
This protects ICN from lysosomal degradation and allows its release into the 
cytosol upon γSec-mediated processing. Overexpression of Rab7 increases 
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Notch signaling, while deletion of HOPS or AP-3 attenuates it. (6) Su(dx) on the 
other hand can redirect Notch and allows its incorporation into the intraluminal 
vesicles, where the Notch receptor will be proteolyzed when the MVB fuses with 
a lysosome. CCV, clathrin-coated vesicle; EE, earlt endosome; LE, late 
endosome; MVB, multivesicular body (Adapted from Wilkin et al. 2008; Baron 
2012) 
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the simplest answer, it would circumvent any rate-limiting checkpoints (i.e. 
ADAM-mediated cleavage of S2) from Notch processing and expose Notch to 
constitutive activation by γSec (De Strooper et al. 1999). This may result in Notch 
signaling that is difficult to regulate. The other two possibilities involve naturally 
occurring changes in the LE environment before it fuses with the lysosome. Here, 
adjustments in ion concentrations (Scott and Gruenberg 2011; Tian et al. 2015), 
especially those of Ca2+ that are important in NRR and HD stability, and the 
gradual acidification of the endosome may either destabilize the NRR or cause 
dissociation of the ECD. Whereas NRR destabilization would mimic a ligand-
induced pull, which then still requires ECD removal by ADAM before γSec can 
recognize Notch (Figure 6B), the immediate dissociation of the ECD at the HD 
domain would leave only a 70aa residual sequence (Figure 6C). γSec has been 
shown to recognize substrates providing the juxtamembrane sequence is <200aa 
in length. However, the longer the sequence, the lower the affinity of γSec to its 
substrate (Struhl and Adachi 2000), suggesting that further processing by ADAM 
still may be required. Conversely, the acidic optimum for γSec activity may 
enable it to simply bypass S2 cleavage and directly process the 70aa-stub 
moiety of Notch (Pasternak et al. 2003).  
In section 1.5 data were presented, largely from studies in Drosophila, 
showing that γSec localizes to and functions in the endosomal compartment, 
thus allowing processing of internalized Notch (Lah and Levey 2000; Vaccari et 
al. 2008; Gupta-Rossi et al. 2004). For two of the proposed pathways discussed  
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Figure 6 – Possible Mechanisms of Notch Processing in the Endosome 
Upon delivery of Notch to the MVB there are 3 possible ways how the endocytic 
environment may prepare the Notch receptor to allow the release of ICN from the 
limiting membrane. (A) Lysozymes (red dots) present in this compartment may 
proteolyze the intraluminal region of Notch and therefore allow γSec cleavage to 
proceed. (B) The change in ion concentrations and decreasing pH may cause the 
NRR of Notch to unravel, mimicking a ligand-mediated pull, which opens the S2 
site for access by ADAM (red scissors), followed by γSec cleavage (blue 
scissors) and dissociation of ICN. (C) Alternatively, the lysosomal environment 
may cause the Notch ECD to dissociate entirely, in which case γSec may directly 
process the 70aa juxtamembrane stub, to which it has a lower affinity then the 
S2-cleaved 12aa residual fragment, or rely on ADAM proteases (light red 
because of uncertain requirement) to increase its affinity for the S3 site.  
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above and shown in Figure 6 (B and C), ADAM activity is required within the 
endosomal compartment as well. Even though ADAM10 and ADAM17 are 
predominantly expressed at the cell surface – constitutively and upon activation, 
respectively (Ebsen et al. 2013) – intracellular shedding of APP in the trans-Golgi 
network by ADAMs has been documented (Skovronsky et al. 2000).  
Once Notch has been cleaved by γSec at the S3 site, ICN is released from 
the membrane and can translocate to the nucleus to signal via its canonical 
pathway or, as is becoming increasingly apparent, via non-canonical pathways 
that may be located either in the nucleus or in the cytoplasm.  
 
1.8 Canonical Notch Signaling Pathway 
Upon entry into the nucleus, the active form of Notch, ICN, regulates the 
transcription of a multitude of target genes. ICN is unable to directly bind DNA 
and relies on its canonical DNA-binding partner RBPJ (also known as C 
promoter-binding factor 1, CBF1 in humans, suppressor of Hairless, Su(H) in 
Drosophila and Lag-3 in Caenorhabditis elegans) (Figure 7). In the absence of 
Notch signal, RBPJ is believed to associate with repressive complexes (Dou et 
al. 1994) comprised of histone-modifying proteins such as histone deacetylases 
(HDAC), and other co-repressors that vary depending on the gene and the 
cellular context, in order to keep NTGs actively suppressed (Kao et al. 1998; 
Hsieh et al. 1999; Zhou et al. 2000). This suppressive function was substantiated  
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Figure 7 – Canonical Notch Signaling Pathway 
Once the Notch receptor has been processed and ICN is cleaved from the 
membrane, it translocates to the nucleus where it interacts with RBPJ and MAML 
to form an activation complex that enables transcription of NTGs.  
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in Drosophila with RBPJ-null mutations, in which some NTGs became de-
repressed and ectopically activated (Morel and Schweisguth 2000; Furriols and 
Bray 2001). Once ICN interacts with RBPJ (Tamura et al. 1995), it displaces the 
repressive complex (Jarriault et al. 1995; Waltzer et al. 1995; Hsieh et al. 1996; 
Kao et al. 1998).  
By contrast, in mammals the view of RBPJ as a repressor has been 
challenged. Using chromatin immunoprecipitation and DNA sequencing 
experiments (ChIP-Seq), it was demonstrated that RBPJ binds the majority of its 
consensus sites dynamically in response to Notch signal, instead of statically,  
which would imply an exchange of repressive for activating complexes upon 
Notch activation (Castel et al. 2013). Furthermore, NTG de-repression upon 
deletion of RBPJ was not detected during TH cell differentiation (Ong et al. 2008) 
or thymocyte maturation (Chari et al. 2010). 
Interactions of ICN and RBPJ at NTG-promoters recruit MAML to form the 
core Notch transcription complex (Wu et al. 2000), leading to gene activation. 
MAML, in turn engages additional factors, among which are the histone 
acetyltransferases (HAT) p300 and pCAF that open up the chromatin, as well as 
complexes containing RNA polymerase II that initiate transcription (reviewed by 
Kovall 2008).  
After Notch signaling has occurred, it is crucial to terminate it in order to 
precisely regulate the level of signaling that the cell receives. ICN is short-lived In 
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the nucleus due to phosphorylation of its C-terminal PEST domain by the 
CyclinC-CDK8 complex (Fryer et al. 2004). Phosphorylation marks ICN for 
ubiquitination by FBW7 and subsequent degradation via the ubiquitin-
proteasome pathway (Tsunematsu et al. 2004). As there are no amplification 
cascades in the canonical Notch signaling pathway and each receptor is 
consumed during signal transduction, only one ICN molecule, and thus one NTG 
transcription complex is formed for each engaged Notch receptor. This balanced 
signal input versus output ratio suggests that the number of Notch receptors that 
are activated determine the signal strength and may be a crucial factor in the 
correct cellular response. In fact, extra copies of the Notch allele as well as 
haplo-insufficiencies result in deleterious defects in Drosophila with deformations 
in embryos and adults (Lyman and Yedvobnick 1995; Fanto and Mlodzik 1999). 
In addition, the half-life of ICN in the nucleus is only a couple of hours (Wu et al. 
2001). This allows not only for great quantitative, but also temporal control of the 
Notch signal, as removal of external stimuli will quickly result in termination of 
NTG expression. 
 
1.9 Non-canonical Notch signaling 
Beyond its role in canonical signaling as a regulator of RBPJ-mediated 
transcription Notch is increasingly being implicated in less well-defined non-
canonical signaling pathways. In most cases the underlying mechanisms and 
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interactions that drive these pathways have not been characterized in detail and 
seem to vary depending on the cellular or experimental context.  
There is evidence that Notch interacts with components of other signaling 
pathways. These include phosphoinositide 3-kinase (PI3K), mammalian target of 
rapamycin complex 2 (mTORC2), Akt, inhibitor of nuclear factor κB (IκB) and β-
catenin in the cytoplasm, and nuclear factor κB (NFκB), Yin Yang 1 (YY1) and 
hypoxia-inducible factor 1 (HIF1) in the nucleus (Ayaz and Osborne 2014). These 
interactions contribute to regulation of cell cycle, metabolism and differentiation. 
For example, in a Notch3 overexpression model in mouse T-cells, interactions of 
Notch3 with IκB Kinase α (IKKα), which deactivates inhibitor of NFκB alpha 
(IκBα), resulted in constitutive activation of NFκB and ultimately leukemia (Vacca 
et al. 2006). In addition, interactions between Notch1 and NFκB were observed in 
peripheral T-cells (Shin et al. 2006 and 2014). Another study using RBPJ-
deficient CD4+ T-cells, in which canonical signaling cannot occur, suggests that 
Notch, in conjunction with NFκB, regulates the differentiation and proliferation of 
peripheral CD4+ T-cells (Dongre et al. 2014). 
In T-cells, Notch also interacts with the mTORC2-Rictor/PI3K/Akt pathway. 
Via interactions with this pathway, ICN that is restricted to the cytoplasm can 
regulate CD4+ T-cell metabolism and provide anti-apoptotic effects (Sade et al. 
2004; Perumalsamy et al. 2009 and 2012).  
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Embryonic/early developmental processes rely more heavily on canonical 
Notch signaling, as seen in mice with RBPJ-deletions that mimic deletions of 
Notch1 and are embryonically lethal (Oka et al. 1995), whereas later 
maintenance of cell populations and activation of the immune system have been 
associated with RBPJ-independent non-canonical signaling events (Ayaz and 
Osborne 2014). If confirmed, this opens the possibility that non-canonical Notch 
signaling pathways involved in pathological events such as T-ALL can be more 
specifically targeted for inhibition, thereby avoiding some of the side effects that 
are seen with complete inhibition of Notch signaling in therapeutic approaches. 
Complete inhibition affects a multitude of cells in the body and usually causes 
gastrointestinal tract toxicity and may diminish healthy stem cell populations 
(Garber 2007). Most of the data revealing non-canonical functions of Notch are 
quite recent and it will be important to elucidate the mechanisms that govern 
these novel pathways.  
Thus, the major goals of this work are: 1) to determine how T-cells regulate 
the activation of Notch via TCR-signaling, and 2) to determine if Notch utilizes 
non-canonical signaling strategies in the proliferation of peripheral T-cells.   
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2 MATERIALS & METHODS 
2.1 Small Molecule Inhibitors  
The γSec inhibitor CompE (Compound E, γ-Secretase Inhibitor XXI), Lck 
inhibitor PP1, and metalloprotease inhibitor TAPI-1 were purchased from 
Cayman Chemical (Ann Arbor, MI, USA). PP3, the inactive analog of PP1, was a 
gift of Dr. Andrew Henderson, Boston University. The dynamin inhibitor Dyngo-4a 
and PKC inhibitor Sotrastaurin were purchased from SelleckChem (Houston, TX, 
USA). The PI3K inhibitor Wortmannin, translation inhibitor cycloheximide, 
ADAM10 inhibitor GI254023X and chloroquine were purchased from Sigma-
Aldrich (St. Louis, MO, USA). An overview of inhibitor functions and mode of 
actions is summarized in Table 1. 
 
2.2 Mice  
CD4-Cre- x RBPJflox/flox (RBPJ+) and CD4-Cre+ x RBPJflox/flox (RBPJ-/-) mice 
were generated previously by our lab (Chari et al. 2010) by intercrossing CD4-
Cre transgenic (Tg) (C57BL/6) mice (Taconic Farms, Germantown, NY) with 
RBPJfl/fl (C57BL/6) mice (Han et al. 2002). In CD4-Cre Tg mice, the enzyme Cre 
recombinase is under the transcriptional control of the CD4-promoter, limiting 
Cre-expression to T-cells as early as the double-positive (CD4+CD8+) stage in 
the thymus. When expressed, Cre excises genomic DNA flanked by flox- 
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Table 1 – Inhibitors 
 
Inhibitor Function 
Chloroquine Endosomal acidification inhibitor that accumulates in the 
endosome, thereby raising the pH, preventing fusion with 
the lysosome, and inhibiting proteolytic enzyme activity 
CompE γSec inhibitor that prevents S3-cleavage of the Notch 
receptor, and thus, ICN generation 
Cycloheximide Inhibitor of protein synthesis that blocks translational 
elongation at the ribosome and prevents synthesis of new 
proteins 
Dyngo-4a Inhibits endocytosis by blocking dynamin, which is a 
GTPase that facilitates endocytic vesicle formation by 
creating a helical polymer around the neck of the vesicle 
and pinching it off of the membrane 
GI254023X ADAM10-specific inhibitor that is 100-fold more effective 
against ADAM10 (IC50 of 5.3nM) than ADAM17 (IC50 of 
541nM) 
PP1 Src family kinase inhibitor with greatest efficacy against 
Lck. Blocks early/proximal TCR signaling events. 
PP3 Inactive analog of PP1 
Sotrastaurin Potent PKC inhibitor with its strongest affinity to PKCθ, the 
isoform most closely associated with TCR signaling  
TAPI-1 Broad-spectrum metalloprotease inhibitor frequently used 
for ADAM17 inhibition, but which also affects ADAM10 
Wortmannin Highly potent PI3K inhibitor 
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sequences (LoxP sites), which in the RBPJflox/flox mice are flanking exons 6 and 7 
of the RBPJ gene, resulting in T-cells deficient in RBPJκ. Mice were genotyped 
by polymerase chain reaction (PCR) analyses of toe DNA using primers 
designed for the Cre-recombinase insert (Cre-F, 5’-CAT CGC TCG ACC AGT 
TTA GT-3’ and Cre-R, 5’- CGA TGC AAC GAG TGA TGA GG-3’) and the floxed 
locus in RBPJ (RBPJFl-F, 5’-GAT AGA CCT TGG TTT GTT GTT TGG G-3’ and 
RBPJFl-R, 5’- CCA CTG TTG TGA ACT GGC GTG G-3’). All animal procedures 
were approved by the Boston University Institutional Animal Care and Use 
Committee (IACUC). 
 
2.3 Cell Lines 
The DO11 T-cell leukemia line was generated (Chari et al. 2010) in our lab 
by culturing thymocytes from a cross-breeding of DO11.10 TCR-Tg mice 
(BALB/c; Murphy et al. 1990) and Ikaros-/- mice (C57BL/6 x SV129) with 
spontaneous leukemogenesis (Urban and Winandy 2004). The JE131 T-
leukemia line was also derived in the Winandy lab from a thymus of an Ikaros-/- 
mouse with spontaneous leukemogenesis (Kathrein et al. 2005). These cell lines 
are both dependent on Notch signaling and either contain constitutively active 
Notch with no known mutation in any of the hotspot regions (DO11), or a 
destabilizing Ala1639Thr substitution in the HD domain as well as a premature 
stop codon, which truncates the PEST domain of Notch, and likely results in ICN 
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with an increased half-life (JE131; Chari and Winandy 2008). The D510 T-cell 
leukemia line does not contain any known mutations in the Notch1 gene and is 
not reliant on ICN signals (Chari and Winandy 2008). 
Phoenix cells (φNX, herein referred to as Phx; Pear et al. 1993) were 
created from the 293T cell line [human embryonic kidney (HEK-293T) cells], and 
contain transgenes encoding gag-pol (encoding core structural proteins and 
reverse transcriptase, respectively) and env (envelope) protein, which are 
necessary transgenes for retrovirus production (see chapter 2.9). 
 
2.4 Cell Culture 
T-cell cultures (primary cells and leukemia cell lines) were grown in RPMI 
1640 medium (GE Healthcare HyClone, Pittsburgh, PA, USA) supplemented with 
10% v/v fetal bovine serum (FBS; HyClone), 50uM β-ME (β-mercaptoethanol), 
4mM L-glutamine, 50U/ml of penicillin and 50μg/ml streptomycin (referred to as 
complete RPMI medium). Phx cells were grown in DMEM medium (HyClone) 
supplemented with 10% v/v FBS (HyClone), 50U/ml of penicillin and 50μg/ml 
streptomycin. All cells were incubated in a humidified atmosphere at 37°C and 
5% CO2. All centrifugation steps with live cells intended for continued culture 
were performed at 200x G for 5min at 4°C. 
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Quantification of live cells was performed using trypan blue exclusion dye 
(HyClone) and counting on a Neubauer improved hemocytometer under the 
microscope. 10μl of cells were first diluted in PBS depending on culture densities, 
with a final 1:2 dilution in trypan blue (Thermo Fisher Scientific, Waltham, MA, 
USA). For assays using small molecule inhibitors, control cultures received 
equivalent volumes of dimethyl sulfoxide (DMSO) vehicle as used in cultures 
treated with inhibitors. 
 
2.5 CD4+ Splenocyte Isolation and Activation 
For CD4+ T-cell purification, spleens from 5-7 week old mice were 
aseptically harvested and ground between two frosted glass slides in ice cold 
complete RPMI media to release the splenocytes. Red blood cells (RBC) were 
lysed with RBC lysis buffer (Santa Cruz, Dallas, TX, USA) for 5min on ice. After 
RBC lysis, cells were resuspended in phosphate buffered saline (PBS) with 
Ca2+/Mg2+, 0.1% w/v bovine serum albumin (BSA), 0.6% w/v sodium citrate 
(“isolation buffer”). Splenocytes were washed and blocked for 15min on ice using 
rat serum (1% v/v; Invitrogen, Waltham, MA, USA) and αCD16/αCD32 Fc-block 
(clone 93, 5μg/ml; eBioscience, San Diego, CA, USA). To isolate CD4+ T-cells 
the Dynabeads® FlowCompTM isolation kit (Invitrogen) was used according to 
manufacturer’s instructions. If indicated, cells were rested overnight at a cell 
density of no more than 3x106 cells/ml in complete RPMI medium supplemented 
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with 10ng/ml IL4 and 10ng/ml IL7 (Peprotech, Rocky Hill, NJ, USA). Resting 
CD4+ cells were activated on culture plates coated with 1μg/ml αCD3 and 1μg/ml 
αCD28 (Bio X Cell, West Lebanon, NH, USA) that were incubated at 4°C 
overnight. In specific cases, rested CD4+ cells were activated with 50ng/ml 
phorbol 12-myristate 13-acetate (PMA) and 200ng/ml ionomycin (Sigma-Aldrich). 
 
2.6 Protein Preparation, Immunoblotting and Western Blot Antibodies 
Whole cell extracts (WCE) were prepared by cell lysis with 420mM NaCl 
lysis buffer (20mM Tris-HCl pH 7.5, 420mM NaCl, 1mM EDTA, 1% v/v NP-40). 
Cytosolic membrane-exclusion lysates were prepared in Tris-HCl buffer (20mM 
Tris-HCl pH 7.5; recommended by AbCam, http://www.abcam.com/ps/pdf/ 
protocols/wb-beginner.pdf). For cytosolic and nuclear fraction protein extracts the 
NE-PERTM extraction kit (Thermo Fisher Scientific) was used according to the 
manufacturer’s instructions. Lysate buffers were supplemented with the protease 
inhibitors leupeptin (10μM), aprotinin (2μg/ml), PMSF (phenylmethylsulfonyl 
fluoride, 1μM), and the phosphoatase inhibitors NaF (sodium fluoride, 1mM) and 
Na3VO4 (sodium orthovanadate, 1mM). All inhibitors were purchased from 
Sigma-Aldrich and added to the lysis buffer immediately before use. 5-10x106 
cells were washed in PBS and subsequently lysed for 30min on ice. Cell debris 
was pelleted at 16000x G and protein supernatant was recovered, quick-frozen in 
liquid nitrogen or dry ice/ethanol bath and stored at -80°C.  
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Protein concentrations were determined using a Bradford assay (Bio-Rad, 
Hercules, CA, USA). 10-25μg of protein extract were denatured with 6X gel 
loading buffer (also known as Laemmli Buffer: 375mM Tris-HCl pH 6.8, 12% w/v 
SDS, 50% v/v glycerol, 0.06% w/v bromophenol blue, 9% v/v β-ME) at 95°C for 
5min. Denatured protein was loaded and electrophoresed on 8% w/v SDS-
polyacrylamide gels (SDS-PAGE) and transferred at 160mA to a polyvinylidene 
difluoride (PVDF) membrane overnight at 4°C.  
Membranes were blocked for 1-2h with 5% w/v milk in Tris-buffered saline 
(TBS, pH 7.6) plus 0.05% v/v Tween-20 (TBST) at room temperature (RT) on a 
shaker. Primary antibodies (Ab) were diluted in TBST plus 5% w/v BSA and 
0.02% v/v NaN3. Blots were incubated overnight at 4°C on a shaker. Primary Abs 
include αICN (Val1744, clone D3B8, 1:200), αAkt (#9272, 1:1000), αpS473-Akt 
(#4058, 1:1000) and αLck (#2752, 1:1000) purchased from Cell Signaling 
Technology (Danvers, MA, USA); αNotch1 (clone 8G10, 1:500) purchased from 
EMD Millipore (Temecula, CA, USA); αActin (#A2066, 1:1000, Sigma-Aldrich); 
αUbiquitin (clone P4D1, 1:500, Santa Cruz); αNucleolin (A300-711, 1:1000, 
Bethyl Laboratories Inc., Montgomery, TX, USA); and αNa+K+ATPase alpha 1 
(clone 464.6, 1:1000, AbCam, Cambridge, MA, USA); and are summarized in 
Table 2. Membranes were washed with TBS 3x for 5min and then incubated with 
horseradish peroxidase (HRP)-conjugated secondary Ab (suspended in 5% w/v 
milk in TBS) for 1-2h at RT on a shaker. Depending on the host of the primary Ab 
the secondary Abs used were goat αRabbit IgG (1:1000), goat αSyrian hamster  
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Table 2 – Western blot antibodies 
 
  Antigen 
Specificity 
Clone/ID Host animal Dilution Source 
1st Ab Actin #A2066 Rabbit 1:1000 Sigma-Aldrich 
 Akt #9272 Rabbit 1:1000 Cell Signaling  
 ICN, Val1744 D3B8 Rabbit 1:200 Cell Signaling  
 Lck #2752 Rabbit 1:1000 Cell Signaling  
 Na+K+ATPase α1 464.6 Rabbit 1:1000 AbCam 
 Notch1 8G10 Syr. Hamster 1:500 EMD Millipore  
 Nucleolin A300-711 Rabbit 1:1000 Bethyl Labs  
 pS473-Akt #4058 Rabbit 1:1000 Cell Signaling  
 Ubiquitin P4D1 Rabbit 1:500 Santa Cruz 
2nd Ab Mouse IgG   Goat 1:1000 JAX 
 Rabbit IgG  Goat 1:1000 JAX 
 Syr. hamster IgG  Goat 1:1000 JAX 
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IgG (1:1000) and goat αMouse IgG (1:1000), which were purchased from 
Jackson ImmunoResearch (West Grove, PA, USA).  
The enhanced chemiluminescence (ECL) reagent, SuperSignalTM West 
Femto (Thermo Fisher Scientific) was used to visualize HRP-conjugated 
antibodies. Light signal was detected using a Bio-Rad Universal Hood II with 
Molecular Imager® ChemiDocTM XRS+ Camera (Bio-Rad). Immunoblots were 
stripped for re-probing with stripping buffer (62.5mM Tris-HCl pH 6.8, 2% w/v 
SDS, 86mM β-ME). Densitometry analyses were performed using ImageJ 
software.  
 
2.7 Flow Cytometry and Fluorochrome-Conjugated Antibodies 
Antibodies for flow cytometric analyses are summarized in Table 3 and 
included: αCD4 (clone L3T4), αCD25 (clone PC61.5), αNotch intracellular 
fragment (clone mN1A), αNotch extracellular fragment (clone 22E5), αJag1 
(clone HMJ1-29). αJag2 (clone HMJ2-1), αDLL1 (clone HMD1-5), αDLL4 (clone 
MHD4-1), rat IgG2aκ isotype control (clone eBR2a) and Armenian hamster IgG 
isotype control (clone eBio299Arm) were purchased from eBioscience; 
MACSelect control antibody and αH-2Kk (referred to as αH2K, clone H100-
27.R55) were purchased from Miltenyi Biotec (San Diego, CA, USA). Antibodies 
were either fluorescein isothiocyanate (FITC), phycoerythrin (PE) or  
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Table 3 – Fluorochrome-conjugated antibodies 
 
Antigen 
Specificity 
Clone or ID Fluorochrome Dilution Source 
CD25 PC61.5 PE/FITC/APC 1:100 eBioscience 
CD4 L3T4 PE/FITC/APC 1:100 eBioscience 
DLL1 HMD1-5 PE 1:100 eBioscience 
DLL4 MHD4-1 PE 1:100 eBioscience 
H-2Kk H100-27.R55 PE/FITC 1:100 Miltenyi Biotec 
Jag1 HMJ1-29 PE 1:100 eBioscience 
Jag2 HMJ2-1 PE 1:100 eBioscience 
Notch mN1A PE 1:100 eBioscience 
Notch-ECD 22E5 PE/APC 1:100 eBioscience 
MACSelect ctrl     PE/FITC 1:100 Miltenyi Biotec 
Rat IgG2aκ  PE/FITC/APC 1:100 eBioscience 
Arm. hamster 
IgG  
 PE 1:100 eBioscience 
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allophycocyanin (APC) conjugated and used at a concentration of 2μg/ml (1:100 
dilution from stock).  
For surface staining, cells were plated in 96-well V-bottom plates at 0.5 to 
1x106 cells per well and washed in PBS. Cells were pre-blocked for 15min on ice 
using αCD16/αCD32 Fc-block (clone 93, 5μg/ml; eBioscience). Fluorochrome-
conjugated Abs were added to the Fc-blocked cells and incubated for another 
15min on ice. For intracellular staining, cells were fixed and permeabilized using 
the Transcription Factor Staining Buffer Set (00-5523, eBioscience) according to 
the manufacturer’s instructions, and subsequently stained with Ab for 15min on 
ice.  
Cells were washed in PBS, filtered through 70μm nylon cell strainers and 
analyzed by flow cytometry on the BD FACSCalibur™ (BD Biosciences, San 
Jose, CA, USA) using CellQuest™ Pro software (BD Biosciences). Additional 
analyses of post-collection data were performed using FlowJo V10 software 
(FlowJo LLC., Ashland, OR, USA). 
 
2.8 Plasmid Generation and DNA Sequencing 
Plasmids containing ICN.NES and ICN.NLS constructs were originally 
created by the Capobianco lab (Jeffries and Capobianco 2000) and gifted to us 
by the Osborne lab at the University of Massachusetts (Amherst, MA). Dried 
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plasmids were reconstituted from Whatman paper using Tris-EDTA (TE) buffer 
(10mM Tris-HCl pH 8.0, 0.1mM EDTA). DH5α™ competent cells (Thermo Fisher 
Scientific) suspended in transformation buffer II (TfBII; 10mM MOPS pH 7.2, 
10mM sodium acetate, 1mM EDTA, 75mM CaCl2, 10mM KCl, 15% v/v glycerol) 
were heat shocked in the presence of plasmid DNA at 42°C for 2min. 
Transformed DH5α™ were then diluted 1:10 in 2.5% w/v luria broth (LB) and 
incubated in a bacterial culture shaker at 37°C for 1h. Bacterial cells were 
subsequently streaked on LB-kanamycin plates and incubated overnight at 37°C.  
DNA plasmid minipreps (Promega, Madison, WI, USA) of individual 
colonies were performed according to manufacturer’s instructions. Step-by-step 
cloning scheme from pEGFP-C1 to MSCV-H2K vectors is described in chapter 
5.2 (Figure 41). Restriction enzymes used included SgrAI, XhoI, BspEI, SalI-HF, 
EcoRI and SacII (New England Biolabs Inc., Ipswich, MA, USA). Restriction 
enzyme digests were performed for 1h at 37°C and DNA fragments were purified 
using the Wizard® SV Gel and PCR Clean-Up System (Promega). Ligations were 
performed using T4 DNA ligase (New England Biolabs) overnight at 17°C. 
DNA plasmid maxipreps (Sigma-Aldrich) of final MSCV.ICN.NES/NLS 
constructs were performed according to manufacturer’s instructions. DNA 
concentrations were quantified using the NanoDrop™ 2000c (Thermo Fisher 
Scientific). Critical regions of the final constructs were sequenced using a primer 
to the internal ribosome entry site (IRES) that is 3’ to the ICN insert. The location 
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for the ‘IRES-reverse’ primer (5’-ACC CCT AGG AAT GCT CGT CAA G-3’) was 
chosen on the opposite 3’5’ strand of the plasmid to allow sequencing to 
proceed towards the insert (Figure 41). DNA sequencing was done by the Boston 
University School of Medicine Molecular Genetics Core Facility (Boston, MA, 
USA). 
MSCV-empty control and pCL-Eco (packaging plasmid for retroviruses) 
vectors were gifted to us by Dr. Neil Clipstone, Loyola University. MSCV-ICN was 
a gift from Dr. Warren Pear, University of Pennsylvania.  
 
2.9 Retroviral Particle Production & Transduction 
Retroviral plasmids and pCL-Eco, which maximizes recombinant retrovirus 
production by supplying additional packaging transgenes (gag-pol and env; 
Naviaux et al. 1996) were transfected into the Phx packaging cell line (Figure 8) 
using the calcium phosphate (Ca2PO4) transfection method. Ca2PO4 crystals 
were produced by mixing 2.5M calcium chloride solution containing the plasmids 
with 2X HEPES-buffered saline (HBS; 50mM HEPES pH 7.05, 10mM KCl, 
280mM NaCl, 12mM Dextrose, 1.5mM Na2HPO4) under constant aeration. DNA-
containing crystals were added to Phx cell cultures. Viral supernatants were 
harvested 48h post transfection.  
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Figure 8 – Schematic of Phx packaging cell line 
Phx cells contain gag-pol and env genes. Cells were transfected with DNA 
plasmids and the booster plasmid pCL-Eco. 
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T-cells were transduced with fresh viral supernatants using spinfection. 
2x106 cells were plated per well in 1ml of viral supernatant supplemented with 
8μg/ml polybrene in a 24-well tissue culture plate. Plates were centrifuged at 
500x G for 2.5h at 32°C. Supernatants were removed and cells resuspended in 
complete RPMI. Cells were cultured for 48h before H2K-expression was 
examined using flow cytometry.  
If the transduction efficiency was below 50%, successfully transduced cells 
were purified on the basis of H2K-expression using the MACSelect Kk microbead 
system (Miltenyi Biotec). Cells were trypsinized (Thermo Fisher Scientific) to 
prevent cell clumping, followed by a 15min incubation at 4°C with magnetic bead-
conjugated αH2K. A magnetic field was applied and H2K-positive cells were 
isolated.  
 
2.10 Immunofluorescent Imaging 
Cells were suspended at a concentration of 105 cells per 200μl PBS+ (PBS, 
0.5% w/v BSA) and cytospun at 500rpm for 5min onto microscopy glass slides 
using the ShandonTM CytoSpin II Cytocentrifuge (Thermo Fisher Scientific). The 
area of cell adhesion was circled with a hydrophobic pen to assist in the staining 
procedure. Cells were fixed with 2% paraformaldehyde for 10min at RT and 
rinsed twice with PBS. Permeabilization was performed with 0.5% Triton X in 
PBS for 15min at RT, followed by three rinses with 0.05% Tween-20 in PBS 
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(PBST). Cells were incubated with blocking buffer (2% w/v BSA, 10% v/v goat 
serum, 0.05% Tween-20 in PBS) for 2h at RT and rinsed once with PBST. The 
primary antibody, αMyc (Santa Cruz), was diluted 1:500 in blocking buffer and 
added to cells overnight at 4°C in a humidified microscope slide box. Slides were 
washed three times in PBST for 15min each. The secondary antibody, Alexa 
Fluor® 594 Goat αMouse (Invitrogen), was diluted 1:500 in PBS and added to 
slides for 1h at RT. Slides were washed twice in PBST for 10min each and then 
rinsed once with PBS. 5μl of Vectashield® mounting medium with DAPI (Vector 
Laboratories Inc., Burlingame, CA, USA) was applied to cells and covered with a 
glass cover slide. Slides were analyzed on the Olympus® BX60F-3 fluorescent 
microscope with QImaging® RetigaTM 2000R Fast-1394 camera (QImaging 
Scientific, Surrey, BC, Canada). Images were merged using ImageJ software.  
The 10μm scale bar in microscopy images represents 81 pixels. Scale bars 
were calculated with the following formula:  
           
                        
                                               
 
       
      
         
 
2.11 RT-qPCR 
RNA was prepared using the SV Total RNA Isolation System (Promega) 
according to the manufacturer’s instructions. cDNA was generated using 
Superscript III (Invitrogen). Primers used for reverse transcription real-time 
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quantitative polymerase chain reactions (RT-qPCR) are listed in Table 4. RT-
qPCR reactions were prepared using SYBR® Green Supermix (Bio-Rad). 
Reactions were run on the MyiQTM Real-Time PCR Detection System (Bio-Rad). 
 
2.12 CFSE Proliferation Assay 
For proliferation assays with non-transduced T-cells, CD4+ T-cells were 
isolated from murine spleens and rested overnight. Subsequently, they were 
loaded with 5μM carboxyfluorescein succinimidyl ester (CFSE) and cultured in 
tissue culture plates that had been coated with 1μg/ml αCD3 and 1μg/ml αCD28 
for 24h. They were then removed from stimulation and expanded for another 48h 
in the presence of 15U/ml IL2. Cells were grown in the presence of 2μM CompE 
or DMSO control.  
Proliferation assays involving transduced CD4+ T-cells, used the following 
protocol. CD4+ T-cells were isolated from murine spleens and activated on 
1μg/ml αCD3 and 1μg/ml αCD28-coated plates. After 24h, cells were transduced 
with fresh retroviral supernatant using the spinfection technique and left on 
stimulation for an additional 48h. At this time, transduction efficiency was 
assessed via analyses of H2K-expression using flow cytometry. H2K+ cells were 
purified if transduction efficiency was low. Cultures were rested for 24h in media 
alone to terminate any Notch signaling. Cells were then loaded with CFSE and 
treated as above.  
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Table 4 – RT-qPCR Primers 
 
Gene Forward Primer Reverse Primer 
HPRT GGATATGCCCTTGACTATAATGAG GCCACAGGACTAGAACACC 
CD25 GCCACGCTTGCTGATGTTG GGATGGTGCCGTTCTTGTAGG 
Deltex1 GGCCAAAACAACCTCAGTCG GCCAGTGCCATTCAAGTTCTTC 
Notch1 TTCCAATGTCAGTGCCCC GTCCCTGTGTAACCTTCTGTAC 
Pre-TCRα GTCATGCTTCTCCACGAGTG      GCTGCCTTCCATCTACCAG 
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Proliferation profiles were analyzed by flow cytometry on the BD 
FACSCalibur™ (BD Biosciences) using CellQuest™ Pro software (BD 
Biosciences). Additional analyses of post-collection data were performed using 
FlowJo V10 software (FlowJo LLC., Ashland, OR, USA). 
 
2.13 Statistics 
Two sample comparisons were performed using 2-tailed, paired student t-
tests. Multi-sample comparisons were analyzed using one-way ANOVA with 
post-hoc Tukey honest significant difference (HSD) test. NS = not significant;       
* < 0.05; ** < 0.01, *** < 0.001  
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3 RESULTS I – KINETICS OF TCR-MEDIATED NOTCH ACTIVATION 
The plasma membrane receptor, Notch, is an important factor in T-cell 
development and continues to play an important role after mature cells are 
released into the periphery. For its induction, the canonical Notch activation 
pathway requires the Notch receptor to be engaged by trans-expressed ligands. 
Upon binding of the receptor, these ligands are endocytosed from the cell 
surface creating a mechanical pulling force that causes conformational changes 
in Notch and relieves the autoinhibitory function of the NRR domain. This allows 
receptor processing to be initiated and ICN to be released from the membrane. 
Yet, in T-cells Notch can become activated simply upon TCR-stimulation in the 
absence of direct Notch receptor ligation (Adler et al. 2003; Palaga et al. 2003). 
Hence, a system must be in place that can activate the receptor without 
mechanical forces acting upon it. In the past years, this unique mode of Notch 
activation in T-cells has been exploited to study downstream functions of Notch 
without characterizing or understanding the underlying mechanisms that connect 
these two signaling pathways. Due to the T-cell-specific nature of this system, it 
may be possible to take advantage of it and interfere with Notch activation in T-
ALL without affecting signaling in other cellular environments. 
To date, nearly all studies regarding Notch activation – ligand-dependent as 
well as independent – have been conducted in Drosophila, with a 
disproportionate emphasis on activation induced by Notch-ligands. In mammalian 
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cells, non-canonical Notch activation has been largely neglected and particularly 
the phenomenon of TCR-mediated Notch activation remains undefined.  
This chapter will focus on the importance of Notch signaling in peripheral T-
cells and the kinetics of TCR-mediated Notch activation. The following chapters 
will investigate the underlying mechanisms connecting the TCR signaling 
cascade to Notch activation, and explore non-canonical downstream functions of 
Notch in peripheral T-cells.   
 
3.1 Notch signaling is required for optimal peripheral T-cell proliferation 
Notch signaling is essential for T-cell development in the thymus and has 
been studied thoroughly. However, Notch also plays a crucial role in the function 
of peripheral T-cells, albeit a not well defined one. Thus, we first sought to 
determine the importance of Notch signaling in mature CD4+ T-cells.  
In the past years, a limited number of studies have attempted to elucidate 
the involvement of Notch in mature T-cell function, but have not achieved a 
consensus regarding the role of Notch in T-cell activation and proliferation. In 
some reports, GSI-induced Notch signal inhibition causes a reduction in the 
proliferative response in cells that have been activated via the TCR (Adler et al. 
2003; Palaga et al. 2003; Guy et al. 2013). Furthermore, deletion of ADAM10 
(Guy et al. 2013) as well as removal of presenilin (Ong et al. 2008), which both 
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lead to blocking of Notch processing, yield similar results. Others, however, have 
found no effect of GSIs on T-cell proliferation when cells were activated with 
Notch ligands (Eagar et al. 2004; Rutz et al. 2005). Moreover, it seems that the 
various ligands have a differential effect on cell proliferation. Whereas DLL4 
increased T-cell proliferation, DLL1 and Jag1 have the opposite effect (Maekawa 
et al. 2003; Rutz et al. 2005). Interestingly, cross-linking Notch receptors through 
the use of plate-bound αNotch1 or immobilized Jag1, as well as stimulation with 
DLL1-expressing APCs lead to inhibition of T-cell proliferation (Eagar et al. 
2004). Because of the limited data and disparities in these results, CD4+ T-cell 
proliferation was tested in our system using αCD3/CD28-mediated TCR-
stimulation to activate Notch.  
While conducting preliminary experiments, it became evident that our 
standard protocol for CD4+ T-cell isolation from the spleen using magnetic bead-
conjugated αCD4, and subsequent T-cell activation needed to be modified. The 
isolation procedure caused an artificial activation of the Notch receptor, which not 
only depleted Notch from the cell surface (Figure 8B), but also initiated ICN 
generation (Figure 8C).  
To ensure the purity of isolated cell samples, isolation buffers generally 
contain chelators, which disrupt divalent cation-dependent protein-protein 
interactions that facilitate cell-adhesion, and thus prevent cells from clumping. 
Chelation, however, also removes Ca2+ from the Notch receptor causing it to 
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shed its ECD and undergo proteolytic processing and activation (Rand et al. 
2000). Hence, two chelators were tested for their ability to activate the Notch 
receptor: 2mM EDTA as suggested for the isolation buffer by the Dynabeads® 
FlowCompTM protocol (Invitrogen) and 0.6% sodium citrate as an alternative, 
which is a much weaker chelator (Keowmaneechai and McClements 2002). 
Whereas EDTA resulted in severe reduction of surface Notch on rested CD4+ T-
cells, sodium citrate showed no effect on Notch expression when incubated at 
37°C for 30min prior to flow cytometric analysis (Figure 8A, left). Thus, in order to 
minimize chelation-mediated activation, without affecting the purity of the cells, 
the EDTA in the isolation buffer was substituted with sodium citrate. Using the 
new formulation, the purity of enriched T-cells remained extraordinarily high 
(Figure 8A, right). 
In addition to chelation, the mechanical stress that splenocytes are 
subjected to during the isolation procedure could contribute to Notch activation, 
since this has been described for other cell types (Liu et al. 2014). Notably, 
resting the isolated CD4+ T-cells overnight restored Notch signaling to an inactive 
state. This was demonstrated by flow cytometric analysis of Notch-ECD, whose 
surface expression was significantly increased compared to freshly isolated 
samples (Figure 8B), and western blot analysis of ICN, which was not detected 
after the resting period (Figure 8C). Thus, to ensure that all Notch signaling is 
inactivated, isolated CD4+ T-cells were rested overnight in complete RPMI media 
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Figure 9 – Notch reconstitution after CD4+ T-cell purification from spleens 
A) On the left, isolated and overnight rested CD4+ T-cells were incubated for 
30min in isolation buffer prepared with either 2mM EDTA or 0.6% sodium citrate. 
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Notch surface expression was analyzed via flow cytometry with antibody against 
the ECD of Notch (8G10) (n=1). On the right, an example of CD4+ T-cell 
enrichment after purification using isolation buffer containing 0.6% sodium citrate 
as measured by αCD4. B) On the left, Notch receptor expression on isolated 
CD4+ T-cells was analyzed via an antibody against the extracellular domain of 
Notch (8G10) either right after CD4+ T-cell enrichment or after an overnight rest 
in complete RPMI media supplemented with 10ng/ml IL4 and 10ng/ml IL7. On 
the right, quantification of 4 independent experiments. C) Isolated CD4+ T-cells 
were lysed either after a 3h or overnight (o.n.) rest in complete RPMI media 
supplemented with 10ng/ml IL4 and 10ng/ml IL7, or immediately after purification 
and ICN levels were examined using an αICN (Val1744) (n=1).  
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supplemented with 10ng/ml IL4 and 10ng/ml IL7 to ensure viability. This resting 
step was performed in all subsequent experiments. 
To examine the effects that Notch signaling has on peripheral T-cell 
function, a reliable and efficient method to inhibit Notch signaling needed to be 
established in our system. Therefore, purified CD4+ T-cells were activated with 
1μg/ml each of plate-bound αCD3 and αCD28 for 6h resulting in maximal ICN 
generation, as will be discussed later in the Results section. These activation 
conditions were used for all subsequent experiments, unless stated otherwise. 
Thirty minutes before as well as during this 6h activation period, cells were 
exposed to 2μM of the highly potent γSec inhibitor Compound E (CompE, γ-
Secretase inhibitor XXI; Ilagan et al. 2011). This treatment effectively prevented 
ICN generation and reduced it to levels of resting cells (Figure 10A+B).  
The effect was replicated in murine DO11 T-leukemia cells, which exhibit 
constitutive Notch activity and high levels of ICN generation (Chari et al. 2010). 
The half-life of ICN of between 45min and 3h is relatively short (Wu et al. 2001; 
Fryer et al. 2004); thus, cells were treated with CompE for 6h in order to 
eliminate pre-formed quantities. Treatment with 2μM CompE for this period of 
time drastically reduced levels of ICN (Figure 10C+D). 
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Figure 10 – 2μM CompE efficiently inhibits ICN generation within 6h 
A-B) Overnight rested CD4+ T-cells were treated with 2μM CompE 30min prior to 
as well as during the 6h activation period. A) Western blot probed with αICN 
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(clone Val1744, 110kDa) and αActin (42kDa) B) ICN values are normalized to 
actin. Quantification of two independent experiments relative to positive controls. 
C-D) Murine DO11 T-leukemia cells were incubated with 2μM CompE for 6h. C) 
Western blot probed as in A. D) ICN values are normalized to actin. 
Quantification of three independent experiments relative to positive control.  
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Having ascertained efficacy, timing and concentrations necessary in our 
system for Notch inhibition by CompE, T-cell activation and proliferation were 
examined. To test the effect of Notch on the proliferative capacity of T-cells, 
purified splenic CD4+ cells were loaded with 5μM of the fluorescent cell 
proliferation dye CFSE. CFSE is a membrane-permeable, fluorescent dye that 
covalently binds to cytosolic proteins. Upon cell division, it is equally distributed 
onto each daughter cell, thus diluting its cellular concentration by half (Figure 
11A). Loaded cells were treated with either 2μM CompE or DMSO vehicle 
control, activated, and allowed to proliferate for 72h. The proliferation profile was 
analyzed via flow cytometry (Figure 11B-D). In the absence of Notch signals, 
CD4+ cells underwent significantly fewer divisions with the average cell having 
divided 2.02 times compared to 2.66 divisions for control treated cells. This 
demonstrates that Notch signaling enhances the proliferative capacity of 
activated CD4+ T-cells.  
Similar effects were observed in the ICN-dependent DO11 cell line, which 
was cultured in the presence or absence of 2μM CompE for four days. Untreated 
cells multiplied exponentially, while the proliferation of Notch-inhibited cells was 
attenuated and numbers began to decline after 3 days (Figure 12). 
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Figure 11 – Notch signaling enhances proliferative potential of CD4+ T-cells 
A) Schematic of cytosolic CFSE dilution upon successive cell divisions. B-D) 
Purified splenic CD4+ T-cells were loaded with 5μM CFSE, activated for 24h and 
allowed to proliferate for another 48h off stimulation in the presence of 15U/ml 
IL2. Cells were grown in the presence of 2μM CompE or DMSO control for the 
full 72h period. B) Example of flow histogram depicting one of four experiments. 
C) Quantification of four independent experiments ±SEM [division numbers are 
arranged from high to low to reflect orientation of CFSE histograms]. 2-tailed, 
paired Student t-test compares treated vs. untreated samples at each time point 
D) Average number of cell divisions within 72h ±SEM (n=4).  
 
  
69 
 
 
Figure 12 – CompE reduces proliferative potential of leukemic cell line 
ICN-dependent murine DO11 T-leukemia cells were grown in the presence or 
absence of 2μM CompE for four days. Counts were taken at 24h intervals and 
cells were maintained at 106cells/ml with complete RPMI media containing fresh 
DMSO or CompE. ±SEM, n=3 
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To examine if Notch signals contribute to the activation of peripheral T-cells, 
purified splenic CD4+ cells were activated and treated with 2μM CompE 30min 
prior to as well as during the 6 or 24h activation period. Surface expression of the 
activation marker CD25 (also known as IL2Rα), which becomes highly 
upregulated upon TCR stimulation, was assessed by flow cytometry. The mean 
fluorescent intensity (MFI) for CD25 was reduced by 25% at both time points in 
cells treated with CompE (Figure 13). This indicates that cell activation is 
significantly attenuated in the absence of Notch signals.  
To investigate the possibility that treatment with CompE has Notch-
independent off-target effects that could affect proliferation, the murine D510 T-
leukemia cell line, which does not exhibit constitutive Notch activation and is not 
reliant on ICN for its survival (Chari and Winandy 2008), was treated with 2μM 
CompE for several days. Cell counts were performed at 24h intervals. No 
differences in cell numbers were observed between treatment groups (Figure 
14A), demonstrating no effect of CompE on cell proliferation or survival. 
Therefore, this suggests that CompE mediates its effects only through the 
inhibition of Notch activation, which is absent in these cells.  
To verify these observations, the Notch-dependent murine JE131 T-
leukemia cell line (Chari and Winandy 2008) was retrovirally transduced with a 
murine stem cell virus (MSCV)-based vector containing a constitutively active 
Notch construct that encodes cleaved ICN – circumventing the need for Notch  
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Figure 13 – Notch signaling affects the activation status of CD4+ T-cells 
On the left, purified splenic CD4+ T-cells were activated for 6h (n=4; p=0.0144) or 
24h (n=8; p<0.0001) in the presence of 2μM CompE or DMSO control. CD25 
surface stains were performed at the designated time points. Values are relative 
to DMSO control. ±SEM. On the right, an example histogram depicting CD25 
expression on cells activated for 24h and treated with or without 2μM CompE. 
 
  
72 
 
cleavage by γSec – and an H-2Kk (H2K) surface-marker that can be used for 
isolation of successfully transduced cells (Figure 14B). The DNA plasmid is 
referred to as MSCV-H2K-ICN. Successfully transduced cells were sorted with 
magnetic microbead-conjugated αH2K. JE131 cells that were retrovirally 
transduced with ICN and treated with CompE grew just as well as untreated 
cells, while proliferation of cells transduced with empty control vector that only 
contains the H2K-marker was severely affected by the inhibitor (Figure 14C). 
These results show that the effects of CompE in our model system are mediated 
through the inhibition of Notch.  
 
3.2 Defining Notch activation kinetics upon TCR-stimulation 
The above results show that Notch signaling contributes to CD4+ T-cell 
activation and proliferation. Having established its importance in these T-cell 
functions, we next looked at the kinetics of Notch activation to give an indication 
as to how the TCR and Notch pathways may interact with each other.  
    We hypothesize that signal transduction originating from the TCR is necessary 
to initiate Notch processing. However, there are numerous mechanisms by which 
this might occur. Notch could be activated rather quickly post TCR-stimulation 
through post-translational modifications such as phosphorylation events that 
result in conformational changes allowing generation of ICN. Alternatively, more 
complex, delayed signaling events may be required. For example, TCR signals  
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Figure 14 – CompE effects are not caused by off-target effects 
A) ICN-independent murine D510 T-leukemia cells were treated with 2μM 
CompE over the course of five days. Counts were taken at 24h intervals and 
cells were maintained at 106cells/ml with complete RPMI media containing fresh 
DMSO or CompE. ±SEM, n=3. B) Schematic of CompE-mediated inhibition of 
Notch processing and function of MSCV-H2K-ICN plasmid. C) ICN-dependent 
murine JE131 T-leukemia cells were transduced with MSCV-H2K-ICN retrovirus, 
H2K-purified and subsequently treated with 2μM CompE over the course of four 
days. Counts were taken at 24h intervals and cells were maintained at 
106cells/ml with complete RPMI media containing fresh DMSO or CompE. ±SEM, 
n=3. 
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may induce gene transcription and synthesis of new proteins, such as Notch-
ligands. In contrast, Notch receptor might be activated as a bystander of TCR 
stimulation. This could be mediated through undefined mechanical forces acting 
upon Notch, causing a destabilization of the extracellular region of the receptor. 
These changes could be brought about by a crowded immunological synapse 
(IS), in which the proximity of many membrane proteins may exert forces on 
Notch that alter intramolecular interactions within the receptor. Such collateral 
activation in the absence of specific signaling events would likely be initiated 
rapidly as well.  
To investigate the kinetics of Notch activation upon TCR stimulation, ICN 
generation was measured over time. For this, we utilized a fluorescently labeled 
Notch antibody (clone mN1A) and an intracellular staining protocol, which have 
been reported to specifically identify ICN within activated T-cells (Dongre et al. 
2014). CD4+ T-cells were analyzed for ICN generation at 2 to 72h post-activation. 
According to the data, Notch activation does not occur significantly until 24h post 
TCR-stimulation (Figure 15A+B).  
In order to ensure that the intracellular signal obtained by flow cytometric 
analysis originated exclusively from cleaved ICN, we took advantage of the ability 
of CompE to inhibit ICN production. In the presence of CompE all ICN-specific 
fluorescent signals should be obliterated. However, signal intensity in treated 
versus untreated cells was not significantly affected by the inhibitor (Figure 15C),  
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Figure 15 – TCR-induced Notch Activation Kinetics Determined by Flow 
Cytometry 
A-B) Purified splenic CD4+ T-cells were activated for the indicated periods of time 
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and stained intracellularly using an antibody detecting the intracellular fragment 
of Notch (clone mN1A) A) Histograms of flow cytometric analyses from a 
representative experiment B) Quantification of three to six independent 
experiments for each time point ±SEM; Statistics obtained with one-way ANOVA 
with post-hoc Tukey HSD test comparing each time point to Notch expression at 
0h. NS, not significant. 
C) CD4+ T-cells were activated and stained as in A, but treated with 0 or 2μM 
CompE. The shaded grey area depicts the difference in signal between the 
CompE treated versus untreated cells. Representative of at least three 
independent experiments for each time point; Student t-test compares treated 
and untreated samples at each time point. NS, not significant.  
D) Schematic of antibody binding sites. Actual binding site for Val1744-Ab is 
depicted. The exact mN1A epitope is undefined and schematic depicts a 
representative binding site. 
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suggesting that the antibody does not specifically interact with activated ICN as 
reported in the literature. Upon further investigation of the antibody, we found that 
it is able to recognize an epitope that is accessible on the intracellular portion of 
the unactivated, full length (FL)-Notch receptor before it is cleaved from the 
membrane (Figure 15D). Therefore, the antibody signal may represent an 
increase in FL-Notch receptor expression at the surface, instead of ICN 
generation. Consequently, the mN1A antibody is not suitable for detection of 
cleaved ICN in activated cells. 
To resolve this issue, another antibody was used to examine ICN 
generation in TCR-stimulated T-cells. The Val1744 antibody recognizes the N-
terminus of ICN, which is newly created upon S3 cleavage of Notch (Figure 15D). 
The epitope at Val1744 is masked in the FL-Notch receptor, and therefore 
specificity is limited to cleaved ICN. CD4+ T-cells were activated for up to 72h 
and levels of ICN production were examined via western blot analyses using 
protein from whole cell extract (WCE) or nuclear fraction lysates (Figure 16). ICN 
was detected as early as 2h after TCR-mediated T-cell stimulation and peaked 
around 6h. After the initial burst, ICN production stopped and concentrations 
declined to insignificant levels at 48-72h post-activation. These findings suggest 
that Notch signaling exerts its functions at early time points in the first 24h of 
TCR signal transduction. Because of the specificity of the Val1744-Ab and 
unambiguous signal, western blot analysis was chosen as the standard method 
of ICN detection in subsequent experiments.  
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Figure 16 – Notch Activation is triggered within 24h of TCR-stimulation 
Purified splenic CD4+ T-cells were activated for the indicated periods of time, at 
which point WCE (n=3) or nuclear protein samples (n=2) were harvested. 
Western blots were probed with αICN (clone Val1744; 110kDa), αNucleolin 
(110kDa) and αActin (42kDa). ICN densitometry values are normalized in respect 
to actin and nucleolin. Values for each time point are relative to 0h ICN 
expression. Statistics obtained with one-way ANOVA with post-hoc Tukey HSD 
test. NS, not significant. 
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3.3 Notch activity is essential in the first 24h post TCR-stimulation for 
optimal proliferation 
To determine the importance of these Notch activation kinetics in T-cells, a 
functional assay was devised to examine its role in T-cell proliferation. In this 
approach, Notch signaling was inhibited either during early activation or later 
during the expansion phase (Figure 17A). To achieve this, CFSE loaded CD4+ 
cells were first activated with αCD3/αCD28 for 24h (activation phase) and then 
cultured for another 48h off stimulation in the presence of IL2 (expansion phase). 
While on stimulation, cells were either treated with 2μM CompE or DMSO 
control, and the treatment was reversed for the following 48h off stimulation. 
Thus, cells with inhibited Notch signaling during the 24h activation phase were 
able to process Notch during the following 48h expansion phase, whereas cells 
that were able to generate ICN during the activation phase were inhibited from 
Notch processing later during the expansion phase. 
Cells deficient in Notch signal during the activation phase displayed 
severely attenuated proliferation, which was comparable to positive control cells 
that were treated with CompE for the entire 72h period (Figure 17B). In contrast, 
cells that were Notch inhibited only at later stages during their expansion phase 
showed minimal effects on proliferation, which was similar to negative control 
samples that were never treated with CompE (Figure 17C). These results  
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Figure 17 – Notch signaling is crucial during TCR engagement  
A) Purified splenic CD4+ T-cells were loaded with CFSE and activated for 24h, 
after which they were removed from stimulation and cultured for another 48h in 
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the presence of 15U/ml IL2. Cells were either treated with 2μM CompE for the 
first 24h while on stimulation or for 48h after removal from stimulation. B-C) 
Histograms of flow cytometric analyses from a representative experiment. D) 
Quantification of the average number of divisions of 5 independent experiments 
±SEM. Average number of division cycles was obtained by multiplying the 
percentage of cells in each division peak with the number of divisions 
represented by that peak. Statistics obtained with one-way ANOVA with post-hoc 
Tukey HSD test. NS, not significant. 
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strongly suggest that Notch signaling plays a crucial role during the early 
activation of T- cells and loses its significance after cells have already been 
stimulated (Figure 17D). These findings agree with results obtained from western 
blot analyses (Figure 16).  
Overall, the above results illustrate a system, in which TCR engagement 
activates Notch signaling within a few hours of T-cell stimulation. However, 
activation kinetics suggests that receptor processing does not occur 
instantaneously (Figure 16), but instead increases steadily until it reaches its 
peak after 6h of TCR stimulation. This suggests the existence of a rate-limiting 
step that slows down Notch activation. 
 
3.4 Canonical Notch ligands are not involved in Notch activation 
The rate-limiting step that causes the steady upregulation of ICN generation 
in the first 6h after TCR-stimulation may be due to a requirement for 
transcriptional upregulation of TCR-induced genes. Thus, we first investigated if 
TCR signaling induces Notch ligand expression on the T-cell surface, which 
could result in canonical, trans-activation of Notch. Surface expression of four of 
the canonical Notch ligands were examined, which included Jag1, Jag2, DLL1 
and DLL4. DLL3 does not activate Notch signaling, and is predominantly 
confined to internal membranes such as the Golgi network (Ladi et al. 2005; 
Geffers et al. 2007). Therefore, its surface expression pattern was not analyzed.  
84 
 
 
Figure 18 – Notch ligands do not contribute to Notch activation  
Purified splenic CD4+ T-cells were activated for 24h. Cells were stained for DLL1 
(clone HMD1-5), DLL4 (HMD4-1), Jag1 (HMJ1-29) and Jag2 (HMJ2-1). Top 
panel depicts example histograms at 0 and 24h post TCR-stimulation. Bottom 
panel represents quantification of four independent experiments. Values were 
normalized to isotype controls ±SEM. Statistics was performed using two-tailed, 
paired student t-test. NS, not significant.  
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Cells were surface stained under unstimulated conditions or 24h post-activation 
(Figure 18). The data indicate that CD4+ T-cells do not express canonical Notch 
ligands in an unstimulated state and do not upregulate their expression within a 
timeframe that would be required for their involvement in Notch activation. 
Nevertheless, it is possible that additional, non-canonical ligands may 
become expressed upon TCR-stimulation, resulting in Notch activation (D’Souza 
et al. 2010). To explore this scenario, CD4+ T-cells were activated for 6h in the 
presence of cycloheximide, an inhibitor of protein synthesis that blocks 
translational elongation at the ribosome. This approach enabled us to examine if 
newly synthesized proteins are required for Notch activation. Western blot 
analyses of ICN levels in cytoplasmic and nuclear lysates from TCR-stimulated 
cells demonstrate that translation of new proteins is not necessary for Notch 
activation (Figure 19). The efficacy of the cycloheximide was tested by analyzing 
total cellular ubiquitin levels, which are depleted upon treatment with this inhibitor 
(Hanna et al. 2003).  
Overall, the results show that Notch receptor processing is induced within 
the first 24h of TCR-stimulation, during which it regulates T-cell proliferation and 
activation. Maximal ICN generation is gradually attained throughout the first 6h 
post activation, which may suggest that rate-limiting events are involved in the 
processing of Notch receptor. However, the mechanism by which TCR signaling 
leads to Notch activation is not mediated through the induced expression of  
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Figure 19 – Synthesis of new Protein is not needed for Notch activation via 
TCR 
A) Purified splenic CD4+ T-cells were treated with the indicated concentrations of 
cycloheximide 30min prior to and during the 6h TCR-activation. Nuclear and 
cytoplasmic protein samples were harvested. Western blots were probed with 
αICN (clone Val1744; 110kDa), αNucleolin (110kDa), αActin (42kDa) and 
αUbiquitin (clone P4D1). B) Quantification of two independent experiments. ICN 
in nuclear and cytoplasmic samples was normalized to nucleolin and actin, 
respectively. Densitometry values are relative to positive controls. 
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newly synthesized proteins, including those that may act as noncanonical 
ligands. Consequently, in T-cells an alternative mechanism must be in place to 
mediate the disruption of the autoinhibitory NRR region of the Notch receptor, 
which emulates the conformational changes triggered by ligand-induced pull. 
 
3.5 Notch signal termination upon prolonged activation 
An interesting observation was made when purified CD4+ T-cells were 
analyzed for Notch ligand expression after prolonged TCR stimulation (48-72h). 
Whereas T-cells do not express Notch ligands in a resting state nor at 24h post 
activation (Figure 18), the Notch ligand Jag2 began to be upregulated upon 48h 
of TCR stimulation (Figure 20). Since Jag2 is not expressed early enough to be 
involved in the activation of Notch, and its upregulation coincides with the 
decrease in ICN signal (Figure 16), its presence on the cell surface may suggest 
an inhibitory cis-interaction with surface Notch receptors. Cis-interactions 
between Notch and some of its ligands have previously been suggested to cause 
inhibition of Notch signaling (reviewed by D’Souza et al. 2010). The process of 
cis-inhibition is very poorly defined and has mostly been studied in invertebrate 
models.  
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Figure 20 – T-cells themselves are capable of expressing Notch ligand  
Purified splenic CD4+ T-cells were activated for the indicated period of time. Cells 
were stained for DLL1 (clone HMD1-5), DLL4 (HMD4-1), Jag1 (HMJ1-29) and 
Jag2 (HMJ2-1). Histograms are representative of at least two experiments per 
ligand and time point. 
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4 RESULTS II – MECHANISMS OF TCR-MEDIATED NOTCH ACTIVATION 
Our model system uses purified CD4+ T-cells, which, as demonstrated 
above, are not induced by TCR-stimulation to express Notch ligands that initiate 
the Notch signal. Therefore, it is unlikely that the same mechanical forces that 
unravel the NRR region during canonical Notch receptor activation are also at 
play in the TCR-mediated processing of Notch. Nonetheless, results from our 
activation kinetics studies demonstrate that Notch processing begins within a 
couple of hours upon stimulation of T-cells, suggesting close contact between the 
two pathways.  
Because of the lack of a mechanical influence on the Notch receptor, it is 
plausible that Notch is required to be translocated into an environment that 
influences the stability of the NRR domain in other ways, allowing receptor 
processing to be initiated. Therefore, the possibility that Notch receptor needs to 
be internalized upon T-cell activation was investigated. As a precedent, in 
Drosophila cells, the requirement for receptor endocytosis in ligand-mediated 
Notch activation has been demonstrated (Seugnet et al. 1997). However, this 
has not yet been established in mammalian cells and especially in T-cells that 
utilize this novel TCR-mediated, ligand-independent activation pathway.  
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4.1 Notch is internalized upon TCR-stimulation 
To investigate if endocytosis is involved in the activation of Notch receptors, 
the internalization of the Notch-ECD was examined. If the full length receptor is 
endocytosed prior to its processing, Notch activation would result in shedding of 
the ECD into the interior of the cell. Thus, it would be detectable in the 
cytoplasmic fraction of cell lysates analyzed on western blots. Accordingly, it was 
tested if the ECD could be detected within the cytoplasm upon TCR-mediated T-
cell stimulation. Using the Thermo Scientific™ NE-PER™ nuclear and 
cytoplasmic extraction kit, the cytoplasmic fraction was harvested from CD4+ 
cells that were activated between 2h and 72h. On the western blots, two bands 
for Notch were detected using an antibody against the EGF-like repeats (clone 
8G10; Figure 21). The lower band migrated at around 200kDa corresponding to 
the ECD fragment of Notch, whereas the upper band ran above the 250kDa 
marker representing the full-length heterodimeric Notch receptor, composed of 
both the ECD and TMF polypeptide fragments, that has a size of around 300kDa. 
Notch-ECD was detected within the cytoplasmic extracts around the same time 
as ICN is generated (Figure 21), suggesting that Notch receptor may indeed be 
processed in internal compartments of the cell.  
To verify that the detected signals exclusively represented endocytosed 
Notch, it needed to be determined if the cytoplasmic extract had been 
contaminated with plasma membrane proteins. To do this, western blots were  
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Figure 21 – Evidence suggesting internalization of Notch receptor upon T-
cell stimulation 
Purified splenic CD4+ T-cells were activated for the indicated period of time, at 
which point cytoplasmic protein extracts were prepared. Western blots were 
probed with αNotch (clone 8G10; 200kDa for ECD, 300kDa for FL-Notch), αActin 
(42kDa). Notch-ECD was normalized to actin and densitometry values are 
relative to 0h. On the right, quantification of two independent experiments. 
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probed with an antibody against the Na+K+ATPase Alpha1, which is an integral 
membrane protein and serves as a plasma membrane marker. All samples were 
positive for Na+K+ATPase (data not shown). This allows for the possibility that the 
Notch-ECD detected on the western blots may corresponds to surface rather 
than endocytosed Notch. 
Consequently, the technique for detecting Notch-ECD in the cytosol was 
modified to minimize the potential of membrane-bound FL-Notch receptor 
contamination. In this experiment, CD4+ T-cells were either resting or activated 
for 6h to induce Notch processing. Before protein extracts were prepared, cells 
were incubated under chelating conditions (2mM EDTA) for 30min at 37°C to 
disassociate uninternalized Notch-ECD from the cell surface. Following this, cells 
were lysed in Tris-HCl pH 7.5 without the use of detergents for 30min on ice, 
which gently ruptures cells through osmotic pressure without disrupting 
membrane structures (http://www.abcam.com/ps/pdf/protocols/wb-beginner.pdf). 
Western blot analyses showed Notch-ECD present in cytoplasmic extracts of 
activated cells, but not in those of resting cells, indicating that FL-Notch is 
internalized (Figure 22A+B). This technique excluded all membrane proteins as 
demonstrated by lack of a band corresponding to Na+K+ATPase in the protein 
extract (Figure 22C). 
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Figure 22 – Internalization of the Notch-ECD upon TCR-stimulation 
A-C) Purified splenic CD4+ cells were activated for 6h and subsequently 
incubated under chelating conditions for 30min. A) The lysates were prepared 
using a Tris-HCl buffer without addition of detergents. The western blot was 
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probed with αNotch (clone 8G10; 200kDa for ECD) and αActin (42kDa). B) 
Notch-ECD was normalized to actin and densitometry values are relative to 
activated cells. Quantification of two independent experiments. C) Lysates were 
either prepared as in A (“Tris-HCl”) or with 420mM NaCl lysis buffer (“Regular 
Buffer”).  
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These results were validated using a flow cytometric approach. CD4+ T-
cells were either used in a resting state or activated for 6h. Subsequently, cells 
were incubated under chelating conditions as described for the previous 
experiment, which reduced the surface Notch-ECD signal significantly (Figure 
23A). Fluorochrome-conjugated αNotch-ECD was then used to detect either cell 
surface Notch1 or, after cell permeabilization, internalized Notch1. Whereas 
internalization of Notch in resting cells was insignificant (p>0.75), activated cells 
displayed a marked increase in Notch endocytosis (1.5-fold), as shown by the 
enhanced signal for αNotch-ECD staining in permeabilized cells compared to 
surface stain (Figure 23B, p=0.026). Using Dyngo-4a, a dynamin inhibitor that 
prevents endocytosis, Notch internalization was significantly blocked (p=0.001), 
and reduced to levels comparable with resting cells (p=0.28).  
Taken together, the flow cytometric (Figure 23) and western blot analyses 
(Figure 22) support a model whereby FL-Notch is internalized after TCR 
stimulation.  
 
4.2 Endocytosis is required for Notch activation 
To determine if endocytosis of Notch receptor is a requirement for its 
activation, ICN levels were quantified after treatment of CD4+ T-cells with Dyngo-
4a for 30min prior to and during the 6h activation period. Nuclear and 
cytoplasmic protein extracts were prepared and analyzed by western blot 
analyses (Figure 24). Dyngo-4a completely inhibited generation of ICN, indicating  
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Figure 23 – Notch-ECD internalization analyzed by flow cytometry 
A) Purified splenic CD4+ T-cells were analyzed resting or activated for 6h. After 
incubation under chelating conditions for 30min at 37°C in 2mM EDTA, cells 
were analyzed for Notch-ECD surface expression to determine chelation efficacy. 
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Values are normalized to ‘Resting, non-chelated’ samples. B) Cells were 
activated and chelated as in A. Surface expression of Notch-ECD was compared 
to intracellular levels in the presence or absence of 100μM Dyngo. To compare 
surface stained and intracellularly stained samples, staining procedures were 
equalized by using the same buffers, and by fixing/permeabilizing surface-
stained samples following their incubation with antibody. Quantification of three 
independent experiments ±SEM; Statistics obtained with one-way ANOVA with 
post-hoc Tukey HSD test. NS, not significant. MFI, mean fluorescent intensity. 
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Figure 24 – Endocytosis is essential to Notch activation 
Purified splenic CD4+ T-cells were treated with the indicated concentrations of 
Dyngo-4a 30min prior to and during the 6h activation. Nuclear and 
cytoplasmic/membrane protein extracts were then prepared. Western blots were 
probed with αICN (clone Val1744; 110kDa), αNucleolin (110kDa) and αActin 
(42kDa). ICN in nuclear and cytoplasmic extracts was normalized to nucleolin 
and actin, respectively. Quantification of two independent experiments ±SEM. 
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that endocytosis of Notch upon TCR stimulation is a crucial step in the induction 
of the Notch signal. To our knowledge, this is the first report demonstrating a 
requirement for internalization of Notch for its activation in mammalian cells using 
endogenous protein. 
 
4.3 Endosome acidification is involved in Notch receptor processing 
One aspect, by which internalization may facilitate Notch activation, is the 
trafficking of the receptor to the late endosome/lysosome, which exhibit gradual 
acidification, calcium efflux, and increased proteolytic activity. This environment 
could contribute to conformational changes in the Notch receptor, which initiate 
its cleavage by ADAM metalloproteases and γSec. In Drosophila, a Deltex-
containing complex can target endocytosed Notch to the limiting membrane of 
MVBs, allowing the intracellular portion of the receptor to protrude into the 
cytoplasm. Upon receptor processing, ICN is released into the cytoplasm of the 
cell (Figure 5). We hypothesized that a similar process may operate in TCR-
induced Notch activation.  
Therefore, we investigated if endosome acidification contributes to 
receptor processing in our system by using chloroquine, which is an endosomal 
acidification inhibitor that accumulates in this compartment. Chloroquine thereby 
raises the pH, prevents fusion with the lysosome, and inhibits proteolytic enzyme 
activity (Steinman et al. 1983). Thirty minutes prior to and during the 6h activation  
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Figure 25 – Endosome acidification contributes to Notch activation  
Purified splenic CD4+ T-cells were treated with the indicated concentrations of 
Dyngo-4a 30min prior to and during the 6h activation. WCE protein extracts were 
then prepared. Western blots were probed with αICN (clone Val1744; 110kDa) 
and αActin (42kDa). Protein was run on same blot; line indicates where 
intervening lanes were removed. ICN signal was normalized to actin signal. 
Quantification of three independent experiments ±SEM; Statistics obtained with 
one-way ANOVA with post-hoc Tukey HSD test. 
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period, CD4+ T-cells were treated with 100μg/ml chloroquine. WCE were 
prepared and analyzed by western blot analyses (Figure 25). Chloroquine 
reduced Notch activation to 57% compared to cells treated with DMSO control, 
demonstrating that the acidic environment in the late endosome and lysosome 
are important to Notch processing after TCR stimulation (Kao et al. 1998). 
In summary, it can be concluded that internalization of the Notch receptor 
into an endocytic compartment is a prerequisite for its activation. The decrease in 
endosomal pH may facilitate denaturation of the Notch-ECD allowing the S2 and 
S3 sites to be cleaved. This process is dependent on TCR signaling for its 
induction, since resting cells lack endocytosed Notch-ECD as well as ICN 
generation (Figure 16, Figure 22, Figure 23). Therefore, we next focused on 
defining how the TCR interacts with the Notch receptor to facilitate its processing.  
 
4.4 Notch processing is induced via signals from the TCR 
TCR cross-linking with plate-bound αCD3 and αCD28 creates a robust 
activation signal for T-cells. Upon activation, multiple enzymes are recruited to 
the immunological synapse (IS) to transduce the TCR signal (Figure 26). The 
TCR is constitutively associated with three CD3 dimers: CD3εδ, CD3εγ and 
CD3ζζ. The CD3zeta (CD3ζ)-chains contain multiple ‘immunoreceptor tyrosine-
based activation motifs’ (ITAM) important for protein recruitment. These motifs 
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Figure 26 – TCR Signaling Cascade with focus on PKC 
TCR/CD3 cross-linking activates a chain of reactions beginning with Lck and 
converging on the activation of PKC. PI3K also facilitates PKC activity by 
increasing the pool of mature PKC proteins. Also shown are inhibitors used in our 
study and where they function.  
Akt, protein kinase B; DAG, diacylglycerol; IP3, inositol trisphosphate; LAT, linker 
of activated T-cells; Lck, lymphocyte-specific protein tyrosine kinase; PDK1, 
phosphoinositide-dependent kinase-1; PI3K, phosphorinositide 3 kinase; PIP2, 
phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidyl-inositol 3,4,5-
trisphosphate; PKC, protein kinase C; PLCγ, phospholipase C γ; ZAP70, zeta-
chain associated protein kinase 70kDa. 
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are phosphorylated by Lck, a T-cell associated tyrosine kinase. Lck is activated 
as a result of multiple Lck-proteins being brought into proximity to each other by 
the co-receptors CD4 or CD8, resulting in trans-autophosphorylation of Lck. The 
tyrosine kinase ‘zeta-chain associated protein kinase 70kDa’ (ZAP70), then binds 
the phosphorylated ITAMs, and is also activated by Lck. ZAP70 is capable of 
phosphorylating a large number of proteins, among which is the linker protein of 
activated T-cells (LAT) that acts as a scaffold molecule for a large number of 
downstream factors. One of the enzymes that binds LAT is phospholipase Cγ 
(PLCγ), which is also a substrate of ZAP70. Once PLCγ has been activated, it 
hydrolyses the membrane component phosphatidylinositol 4,5-bisphosphate 
(PIP2) into the secondary messengers inositol trisphosphate (IP3) and 
diacylglycerol (DAG), which facilitates the release of calcium from internal stores 
and acts as membrane-anchors for other proteins, respectively. DAG is a potent 
activator of protein kinase C (PKC), which in turn can trigger multiple 
downstream pathways important in cell activation, proliferation and survival. 
However, in order to be fully activated, PKC first must undergo maturation steps 
that are facilitated by phosphoinositide-dependent kinase-1 (PDK-1). PDK-1 is 
recruited to the membrane by binding to phosphatidylinositol 3,4,5-trisphosphate 
(PIP3), an efficient membrane anchor, that is generated by phosphorinositide 3-
kinase (PI3K). This PIP3-mediated recruitment enhances interactions between 
PDK-1 and its substrates, which co-localize to the IS.  
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To unravel the connections between the TCR and Notch, a panel of 
inhibitors blocking various parts of the TCR signaling cascade, have been 
utilized. This strategy was used to determine which signals are important in 
Notch activation. PP1 is a Src family kinase inhibitor with greatest efficacy 
against Lck, Sotrastaurin is a PKC family inhibitor and wortmannin is an inhibitor 
of PI3K (Figure 26). 
To investigate if Notch becomes internalized and activated as a result of 
direct TCR signaling events, or as a bystander of mechanical receptor cross-
linking, PP1 was utilized to block TCR signal transduction. CD4+ T-cells were 
treated with PP1, as well as PP3, its inactive analog, 30min prior to and during 
the 6h activation period. WCE were subsequently prepared and analyzed via 
western blot. PP1 at 10μM blocked activation of Lck completely as determined by 
its phosphorylation status (Figure 27A), whereas a small portion of Lck remained 
in its active, phosphorylated state at concentrations of 3.5μM (Figure 27B). This 
is reflected in the levels of ICN that are produced during this treatment. 10μM of 
the inhibitor resulted in a complete loss of ICN generation (Figure 27A), while at 
lower concentrations the reduction was limited to 50% of PP3-treated control 
values (Figure 27B). Because of the amplifying nature of the TCR cascade, weak 
signals are multiplied at each step of the pathway. This could explain the 
detection of significant levels of ICN in samples with low levels of active Lck. 
Exposure of cells to 10μM PP3 had no effect on Lck or Notch activation (Figure 
27C).  
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Figure 27 – Notch activation is directly mediated by TCR signaling  
Purified splenic CD4+ T-cells were treated with the indicated concentrations of 
PP1 or PP3 starting 30min prior to activation and lasting throughout the 6h 
activation phase. WCE were analyzed by western blot with αICN (clone Val1744; 
110kDa), αLck (56kDa for Lck and 58kDa for pLck) and αActin (42kDa). ICN 
signal was normalized to actin signal and densitometry values are relative to 
positive control. Quantification of three independent experiments ±SEM; 
Statistics obtained with one-way ANOVA with post-hoc Tukey HSD test. 
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To verify that Notch activation occurs as a direct effect of TCR-mediated 
signaling and is not a byproduct of TCR-receptor cross-linking at the surface, 
CD4+ T-cells were activated with 50ng/ml phorbol 12-myristate 13-acetate (PMA) 
and/or 200ng/ml ionomycin for 6h. These compounds function by mimicking 
diacylglycerol (DAG) and releasing intracellular Ca2+ stores, respectively, both of 
which are important secondary messengers vital to a complete TCR signal. 
When ICN levels were analyzed via western blot, the combination of PMA and 
ionomycin, simulating a robust activation signal, resulted in strong induction of 
ICN generation (Figure 28). This substantiates our contention that signaling 
events initiated by the TCR directly mediate Notch activation.  
 
4.5 PKC is pivotal in Notch processing 
Interestingly, PMA, a DAG homolog, on its own was also able to stimulate 
strong ICN generation, albeit only half as potently as in conjunction with 
ionomycin (Figure 28). In contrast, ionomycin did not show such an effect. PMA 
is known to be a strong, irreversible inducer of protein kinase C (PKC; Mochly-
Rosen et al. 2012), which requires DAG for its activation (Liu and Heckman 
1998; Mochly-Rosen et al. 2012). Therefore, it was examined if PKC is 
necessary for Notch activation by blocking its activity with sotrastaurin, a potent 
PKC inhibitor with its strongest affinity to PKCθ, the isoform most closely 
associated with TCR signaling (Figure 26; Evenou et al. 2009). CD4+ T-cells  
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Figure 28 – TCR signals can activate Notch in the absence of receptor 
cross-linking 
Purified splenic CD4+ T-cells were activated with the indicated concentrations of 
PMA and/or ionomycin for 6h. Western blots were probed with αICN (clone 
Val1744; 110kDa) and αActin (42kDa). ICN signal was normalized to actin signal 
and densitometry values are relative to combination treatment with PMA and 
ionomycin. Quantification of three independent experiments ±SEM; Statistics 
obtained with one-way ANOVA with post-hoc Tukey HSD test. 
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were exposed to 10μM sotrastaurin for 30min prior to and during the 6h 
activation period. WCE were subsequently prepared and analyzed by western 
blot. Sotrastaurin effectively blocks ICN generation to the baseline levels 
expressed in resting cells, demonstrating that PKC activity is crucial to Notch 
activation (Figure 29). 
Before PKC is capable of being fully activated through DAG/PMA, it first 
must undergo maturation to achieve catalytic competence through 
phosphorylation of three serine/threonine residues. PDK-1 phosphorylates the 
activation loop within the catalytic domain of PKC at Thr500. Subsequently, 
mammalian target of rapamycin complex 2 (mTORC2), which is also known as 
PDK-2, phosphorylates Thr641 and Ser660 at the C-terminus of PKC. This results 
in mature, but inactive PKC (Newton 2010). In this mature form, PKC is locked in 
the catalytically competent state, which is thermally stable, phosphatase-resistant 
and poised for activation (Bornancin and Parker 1996; Edwards et al. 1999). 
Under most studied in vitro conditions, more than 90% of PKC is in the mature 
form (Newton 2001). This could be a result of PDK-1 exhibiting high basal 
activity, especially in in vitro settings (Toker and Newton 2000).  
PDK-1 is thought to be regulated mainly by its localization (Pearce et al. 
2010), which is facilitated by PI3K-mediated generation of PIP3. This recruits 
PDK-1 to the membrane and into proximity of PKC, which substantially enhances 
maturation of PKC (Figure 26). Therefore, we investigated if PI3K function is  
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Figure 29 – PKC facilitates Notch activation 
Purified splenic CD4+ T-cells were treated with the indicated concentration of 
sotrastaurin starting 30min prior to activation and lasting throughout the 6h 
activation period. WCE were analyzed with αICN (clone Val1744; 110kDa) and 
αActin (42kDa). ICN signal was normalized to actin signal and densitometry 
values are relative to positive control. Quantification of three independent 
experiments ±SEM; Statistics obtained with one-way ANOVA with post-hoc 
Tukey HSD test. 
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required for ICN generation by treating CD4+ T-cells with wortmannin, a highly 
potent PI3K inhibitor. Cells were treated for 30min prior to and during the 6h 
activation period, upon which WCE were prepared and analyzed via western blot. 
Wortmannin, at a concentration of 100nM, inhibited Akt phosphorylation. This 
indicates that PI3K activity, which is necessary for this phosphorylation step to 
occur, was efficiently blocked (Figure 30). ICN production was inhibited by 50% 
compared to activated cells that were untreated (Figure 30). These results 
suggest that PI3K and PDK-1 through the maturation of PKC are involved in ICN 
generation.  
Because of the stability and longevity of PKC in its mature but inactive 
state, it is possible that there is a large pool of mature PKC available for 
activation by DAG, even in the presence of PI3K inhibition. Once this pool of 
PKC is activated, however, it is rapidly targeted for degradation (Lu et al. 1998). 
Thus, upon activation of the T-cell in the presence of wortmannin, ICN generation 
would be able to continue until the activated pool of PKC was degraded. 
Following that, Notch processing would cease and ICN levels decrease due to its 
relatively short half-life. This may explain the significantly higher ICN signal that 
was generated in the presence of 100nM wortmannin as opposed to that 
generated in the presence of the PKC inhibitor, sotrastaurin.  At a longer 
incubation period with wortmannin or a PDK-1 inhibitor, we hypothesize that the 
ICN signal would return to a resting cell baseline level.  
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Figure 30 – PI3K is involved in Notch activation 
Purified splenic CD4+ T-cells were treated with the indicated concentration of 
wortmannin starting 30min prior to activation and lasting throughout the 6h 
activation period. WCE were analyzed by western blot with αICN (clone Val1744; 
110kDa), αAkt (60kDa), αpAkt (60kDa) and αActin (42kDa). ICN signal was 
normalized to actin signal and densitometry values are relative to positive control. 
Quantification of three independent experiments ±SEM; Statistics obtained with 
one-way ANOVA with post-hoc Tukey HSD test. 
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Overall, these results show that ICN generation requires activation of PKC. 
This is achieved through cross-linking of the TCR, which initiates signaling 
though Lck and PI3K, culminating in DAG production and PDK-1 activation.    
 
4.6 Notch cleavage by ADAMs is required for TCR-induced ICN generation 
PKC is an activator of ADAM metalloproteases (Kveiborg et al. 2011; Thorp 
et al. 2011). Thus, we examined if the two ADAMs associated with Notch 
activation, ADAM10 and ADAM17, are required for Notch activation through this 
alternative TCR-induced pathway or if the endosomal environment makes this 
step superfluous by removing the Notch-ECD through other means. Two ADAM 
inhibitors were utilized: TAPI-1, which is a broad-spectrum metalloprotease 
inhibitor frequently used for ADAM17 inhibition, but which also affects ADAM10; 
and GI254023X, an ADAM10-specific inhibitor that is 100-fold more effective 
against ADAM10 (IC50 of 5.3nM) than ADAM17 (IC50 of 541nM; Ludwig et al. 
2005).  
CD4+ T-cell cultures were exposed to TAPI-1 or GI254023X for 30min 
before and during the 6h activation period, whereupon WCE were prepared and 
analyzed via western blot. Treatment with both inhibitors caused a severe 
reduction in ICN production (Figure 31). This demonstrates that ADAM-
metalloproteases are important for Notch cleavage post TCR-stimulation.   
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Figure 31 – ADAM cleavage is required for TCR-mediated Notch activation 
Purified splenic CD4+ T-cells were treated with the indicated concentration of 
TAPI-1 or GI254023X starting 30min prior to activation and lasting throughout the 
6h activation period. WCE were analyzed by western blot with αICN (clone 
Val1744; 110kDa) and αActin (42kDa). ICN signal was normalized to actin signal 
and densitometry values are relative to positive control. Quantification of at least 
two independent experiments ±SEM; Statistics obtained with one-way ANOVA 
with post-hoc Tukey HSD test. 
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4.7 Model of Mechanisms underlying TCR-induced activation of Notch in 
CD4+ T-cells 
In summary, taking all this data together, we propose a novel model of 
Notch activation that is unique to T-cells. In this model, signals from the TCR and 
CD28 co-receptors culminate in the activation of PKC. CD28-associated PI3K, 
through the generation of PIP3 and PDK-1 activation, facilitates the maturation of 
PKC. Meanwhile, signals from the TCR, transduced via Lck and PLCγ, result in 
the generation of DAG, which triggers the activation of the matured PKC. 
Subsequently, PKC activates ADAM-metalloproteases. However, the Notch 
receptor is autoinhibited when expressed on the plasma membrane. T-cell 
activation also initiates Notch receptor internalization into the endocytic 
compartment through dynamin-dependent processes. In the endosome, changes 
in the chemical environment alter the conformation of the Notch receptor and 
alleviate NRR autoinhibition. Once the receptor is susceptible to cleavage, 
ADAM-metalloproteases can initiate Notch processing. This will be discussed in 
greater detail in the Discussion chapter.   
 
4.8 Notch activation in T-leukemic cell lines requires endocytosis despite 
Notch mutations 
To investigate if the mechanisms that contribute to Notch activation in 
primary T-cells are also in play in T-leukemic cells, the DO11 and JE131 T-
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leukemia cell lines were subjected to select inhibitors as well. Both lines exhibit 
constitutive ligand-independent ICN generation (Figure 32, no treatment lanes; 
Kathrein et al. 2005; Chari and Winandy 2008). However, JE131 cells contain 
known mutations in the HD domain, which destabilize the Notch-ECD and 
contribute to constitutive activation, as well as mutations in the PEST domain that 
extend ICN half-life, while DO11 cells do not carry any of the known hot spot 
mutations in either of the domains (Chari and Winandy 2008).  
To investigate if endocytosis of Notch remains an integral part of receptor 
activation in a leukemic setting, both cell lines were exposed to Dyngo-4a for 6h. 
This time frame is sufficient to see reductions in levels of previously generated 
wild-type ICN, since the half-life of ICN is between 45min to 3h (Wu et al. 2001; 
Fryer et al. 2004). Dyngo-4a treatment of DO11 cells abrogated Notch 
processing drastically but not completely, whereas Dyngo-4a treatment of JE131 
cells did not result in decreases of the same magnitude (Figure 32).  
It is possible that the persistent ICN signal in endocytosis-inhibited JE131 
cells is caused by Notch processing that is independent of receptor 
internalization; perhaps because of an unstable Notch receptor that can be 
processed at the cell surface due to the HD domain mutations. Another 
possibility, however, is that despite the requirement for endocytosis, experimental 
results are obscured by pre-formed ICN generated before the start of Dyngo-4a 
treatment. The Notch PEST-domain mutations that exist in these cells may  
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Figure 32 – Dyngo-4a treatment reduces ICN signals in DO11 T-leukemia 
cells, but not in PEST-truncated Notch JE131 T-leukemia cell lines 
DO11 and JE131 T-leukemia cells were treated with the indicated concentration 
of Dyngo-4a for 6h. WCE were analyzed byt western blot with αICN (clone 
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Val1744; 110kDa for ICN-WT and 97kDa for PEST-truncated ICN) and αActin 
(42kDa). ICN signal was normalized to actin signal and densitometry values are 
relative to positive control. Quantification of two independent experiments for 
each cell line ±SEM. 
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stabilize ICN to a degree that prevents its degradation within the 6h treatment 
period.   
To determine if either of these mechanisms contributes to the inability of 
Dyngo-4a to reduce levels of ICN in JE131 cells, these cells were treated with 
CompE. CompE would prevent receptor processing regardless of HD mutations, 
through the inhibition of γSec and blocking of the obligate S3-cleavage event, 
and consequently attenuate the ICN signal detected on western blots. If, 
however, the persistent ICN signal in JE131 cells is a result of PEST mutations, 
CompE treatment for 6h, which merely inhibits new ICN from being generated, 
may not be long enough to eliminate the pre-formed ICN pool.  
Like Dyngo-4a treatment, treatment of JE131 cells with CompE for 6h did 
not decrease levels of ICN to the same extent as seen in DO11 cells (compare 
Figure 33 and Figure 10), indicating that PEST-domain mutations in JE131 cells 
likely increase the half-life of ICN such that it is protected from degradation in a 
6h time frame. These results uphold the possibility that, as observed in DO11 
cells, endocytosis is also required in JE131 cells, even though ICN levels remain 
high upon Dyngo-4a treatment.   
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Figure 33 – CompE treatment of JE131 cells for 6h does not eliminate ICN 
signals 
JE131 T-leukemia cells were treated with the indicated concentration of CompE 
for 6h. WCE were analyzed by western blot with αICN (clone Val1744; 97kDa for 
PEST-truncated ICN) and αActin (42kDa). ICN signal was normalized to actin 
signal and densitometry values are relative to positive control. Quantification of 
three independent experiments ±SEM. 
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Thus, to test if endocytosis of FL-Notch occurs in these cells, internalization 
of the Notch-ECD was investigated. After JE131 cells were incubated under 
chelating conditions for 30min to remove surface Notch-ECD, cytoplasmic protein 
extracts were prepared using the Tris-HCl buffer described above to prevent 
membrane protein contamination of the sample. Using western blot analyses, 
significant quantities of Notch-ECD were detected in the cytosol of JE131 cells. 
These levels were significantly decreased in cells, in which endocytosis was 
inhibited via Dyngo-4a (Figure 34). These data suggest that internalization of the 
receptor does occurs prior to its processing, causing an accumulation of ECD 
inside the cell.    
Overall, these results provide evidence that receptor endocytosis occurs 
even in T-leukemic cell lines as a prerequisite step of Notch activation. The 
decreased stability of the receptor as a result of HD-mutations may not 
circumvent the need for the translocation of the receptor into the endocytic 
compartment where it becomes processed.  
To investigate the involvement of TCR signaling pathways in Notch 
activation the Notch-dependent DO11 T-leukemia cells were selected for further 
experiments, because of the lack of PEST-domain mutations that extend the half-
life of ICN and impede experimental readouts.    
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Figure 34 – Notch internalization occurs in leukemia cells expressing 
mutated Notch1 
JE131 T-leukemia cells were treated with the indicated concentration of Dyngo-
4a for 6h. Cytoplasmic protein extracts were analyzed by western blot with 
αNotch (clone 8G10; 200kDa for ECD, 300kDa for FL-Notch) and αActin 
(42kDa). Notch signal was normalized to actin signal and densitometry values 
are relative to negative control. Quantification of three independent experiments 
±SEM. 
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4.9 Notch activation in T-leukemia cells requires Lck, but is independent 
of ADAM-mediated cleavage 
To elucidate if TCR signaling pathways are required for Notch activation in 
T-leukemia cells, DO11 cells were exposed to PP1 for 6h and ICN generation 
was quantified by western blots. Blockage of Lck activation with PP1 led to a 
marked decrease in ICN levels (Figure 35). This result suggests that pathways 
similar to those induced through TCR activation in peripheral CD4+ cells are 
necessary for Notch processing in T-leukemia cells.  
However, when DO11 cells were treated with wortmannin or sotrastaurin, 
there was no effect on ICN generation (Figure 36A+B), suggesting that cleavage 
of Notch by ADAMs may not be required in these cells. This was confirmed by 
treatment of cells with the ADAM-inhibitors TAPI-1, GI254023X or a combination 
of both, which did not affect ICN levels (Figure 36C).  
A possible mechanism for this ADAM-independent mode of Notch 
activation, uncovered in the DO11 leukemia cells and not previously described 
for Notch, could be an increased propensity to unravel the Notch receptor when it 
reaches the endocytic environment. The pathway leading to constitutive Notch 
activation in DO11 cells is, to date, unknown. Although Notch1 contains no 
mutations in the region of the HD domain that are considered ‘hot spots’, further 
analyses of the Notch1 HD domain sequence has not been performed. Perhaps, 
there are HD mutations that destabilize the NRR region to such a degree that  
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Figure 35 – TCR signaling pathways are involved in Notch activation in 
DO11 leukemia cells 
DO11 T-leukemia cells were treated with the indicated concentration of PP1 for 
6h. WCE were analyzed by western blot with αICN (clone Val1744; 110kDa) and 
αActin (42kDa). ICN signal was normalized to actin signal and densitometry 
values are relative to positive control. Quantification of two independent 
experiments ±SEM. 
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Figure 36 – ADAM cleavage is not necessary for Notch processing in DO11 
leukemia cells 
DO11 T-leukemia cells were treated with the indicated concentrations of A) 
wortmannin, B) sotrastaurin, or C) TAPI-1 and/or GI254023X for 6h. WCE were 
analyzed by western blot with αICN (clone Val1744; 110kDa), αAkt (60kDa), 
αpAkt (60kDa) and αActin (42kDa). ICN signal was normalized to actin signal 
and densitometry values are relative to positive control. Quantification of at least 
two independent experiments for each inhibitor ±SEM. 
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changes in the endocytic environment are sufficient to cause complete 
dissociation of the Notch-ECD, as opposed to merely unraveling the NRR as 
occurs in wild-type Notch. This would leave behind only the juxtamembrane 
region of the TMF, at which point the constitutively active γSec could cleave the 
receptor to generate ICN.  
However, chloroquine treatment, which disrupts the acidification of the 
endosome, did not affect ICN processing (Figure 37). This suggests that receptor 
instability is not the cause of ADAM-independent Notch processing. Therefore, 
the mechanism by which Notch activation occurs in the absence of ADAMs in 
these cells is still a mystery and merits further study. 
In conclusion, PKC-induced ADAM activity is not a prerequisite for Notch 
activation in these leukemia cells. However, interfering with TCR signaling 
pathways and endocytosis, through the use of PP1 and Dyngo-4a, respectively, 
does have a detrimental effect on Notch receptor processing. Therefore, we 
propose that there is an additional signaling pathway, perhaps induced by Lck, 
that causes the endocytosis of Notch, which is required for this activation. This 
signal may also play a role in primary cells and will need to be investigated. 
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Figure 37 – Acidification of the endosome does not contribute to ICN 
generation in DO11 cells 
DO11 T-leukemia cells were treated with the indicated concentration of 
chloroquine for 6h. WCE were analyzed by western blot with αICN (clone 
Val1744; 110kDa) and αActin (42kDa). ICN signal was normalized to actin signal 
and densitometry values are relative to positive control. Quantification of three  
independent experiments ±SEM. 
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5 RESULTS III – T-CELL PROLIFERATION IS MEDIATED BY NON-
CANONICAL NOTCH SIGNALING 
Upon successful Notch activation – either through canonical, ligand-
mediated or non-canonical, TCR-mediated activation – signal transduction is 
initiated by the release of ICN from the membrane-bound receptor. This signal 
can be divided into canonical and non-canonical categories, as well. In the 
canonical Notch signaling pathway, ICN generation is followed by its immediate 
translocation to the nucleus where it interacts with its DNA-binding partner RBPJ. 
Together with MAML, a transcriptional co-activator that recruits various auxiliary 
factors, the core transcriptional activation complex is formed (Figure 7). Initially, 
Notch was believed to mediate its effects exclusively through activating the 
expression of Notch target genes (NTGs). However, in light of recent studies and 
experiments in our lab, it is becoming increasingly evident that Notch is not 
limited to RBPJ-dependent signaling, but is capable of a much broader spectrum 
of molecular interactions that go beyond its role as a transcriptional regulator. 
Potential new, non-canonical roles of ICN may include its function as a 
transcription factor utilizing DNA-binding partners besides RBPJ, or involve extra-
nuclear interactions with other signaling cascades.  
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5.1 RBPJ is dispensable for T-cell proliferation  
We have shown that Notch is required for optimal T-cell proliferation and 
activation (Figure 11 and Figure 13). To investigate if RBPJ, and hence the 
canonical Notch signaling pathway, is required for peripheral T-cell function, the 
proliferative capacity of RBPJ-sufficient (RBPJ+) and RBPJ-deficient (RBPJ-/-) T-
cells was compared. These cells were obtained from mice that were generated 
by crossing CD4-Cre transgene (tg) mice with RBPJ-floxed mice. In these mice, 
sequences encoding the enzyme Cre recombinase are under the transcriptional 
control of the CD4-promoter, limiting Cre-expression to only T-cells as early as 
the double-positive (CD4+CD8+) stage. Cre then excises genomic DNA flanked 
by flox-sequences (LoxP sites), which in this model are located flanking exons 6 
and 7 of the RBPJ gene. This results in T-cells deficient in RBPJ. CD4+ T-cells 
were isolated from spleens of CD4-Cre- x RBPJflox/flox (RBPJ+) and CD4-Cre+ x 
RBPJflox/flox (RBPJ-/-) mice, loaded with 5μM CFSE and activated with plate-bound 
αCD3/αCD28. Cells were analyzed by flow cytometry after a 24h antibody-
stimulation period, followed by a 48h expansion period in the presence of IL2. 
Interestingly, lack of RBPJ has no effect on T-cell proliferation (Figure 38).  
To substantiate that the canonical Notch signaling pathway does not 
influence T-cell proliferation, a second approach was utilized. The experiment 
was repeated using only RBPJ-/- T-cells that were treated with or without 2μM 
CompE. In the absence of RBPJ, these cells do not have a functional canonical 
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Notch signaling pathway. An effect of CompE treatment on the proliferation of 
these cells would therefore signify that Notch signaling utilizes RBPJ-
independent pathways to regulate cell proliferation. Notably, CompE reduced the 
proliferation of RBPJ-/- T-cells by 25% after 72h (Figure 39A-C) as well as CD25 
expression at 6h and 24h post activation (Figure 39D), indicating that these cells 
remain sensitive to GSI treatment in the absence of RBPJ.  
The notion that the effects of Notch on proliferation are mediated 
independently of RBPJ is corroborated when proliferation profiles of RBPJ+ and 
RBPJ-/- cells cultured in the presence of 2μM CompE are compared. The 
sensitivity to GSI of both cell populations is identical and their proliferative 
capacity is indistinguishable (Figure 40). These findings indicate that proliferation 
of peripheral T-cells is mediated via non-canonical, RBPJ-independent Notch 
signaling pathways.  
 
5.2 Generation of retroviral ICN.NES and ICN.NLS constructs  
The data suggest that RBPJ-independent Notch signaling pathways play a 
significant role in regulating proliferation of peripheral T-cells. To characterize 
these non-canonical Notch signaling pathways, we used retroviruses generated 
from constructs originally created by the Capobianco lab (Jeffries and 
Capobianco 2000). DNA plasmids containing these constructs were gifted to us  
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Figure 38 – RBPJ is not required for optimal T-cell proliferation  
Purified splenic RBPJ+ or RBPJ-/- CD4+ T-cells were loaded with 5μM CFSE, 
activated for 24h and allowed to proliferate for another 48h off stimulation in the 
presence of 15U/ml IL2. A) Example of flow histogram depicting one of four 
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experiments. B) Quantification of four independent experiments ±SEM [division 
numbers are arranged from high to low to reflect orientation of CFSE 
histograms]. 2-tailed, paired Student t-test compares RBPJ+ vs. RBPJ-/- samples 
at each time point C) Average number of cell divisions within 72h ±SEM 
(p=0.8694, n=4). 
 
134 
 
 
135 
 
Figure 39 – RBPJ-/- cells remain sensitive to CompE-induced inhibition of 
Notch signaling 
Purified splenic RBPJ-/- CD4+ T-cells were loaded with 5μM CFSE, activated for 
24h and allowed to proliferate for another 48h off stimulation in the presence of 
15U/ml IL2. Cells were grown in the presence of 2μM CompE or DMSO control 
for the full 72h period. A) Example of flow histogram depicting one of four 
experiments. B) Quantification of four experiments ±SEM [division numbers are 
arranged from high to low to reflect orientation of CFSE histograms]. 2-tailed, 
paired Student t-test compares treated vs. untreated samples at each time point. 
C) Average number of cell divisions within 72h (p=0.0036, n=4).  
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Figure 40 – Sensitivity to CompE is identical in RBPJ+ and RBPJ-/- cells  
Purified splenic RBPJ+ or RBPJ-/- CD4+ T-cells were loaded with 5μM CFSE, 
activated for 24h and allowed to proliferate for another 48h off stimulation in the 
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presence of 15U/ml IL2. Cells were grown in the presence of 2μM CompE for the 
full 72h period. A) Quantification of four experiments ±SEM [division numbers are 
arranged from high to low to reflect orientation of CFSE histograms]. 2-tailed t-
test compares RBPJ+ vs. RBPJ-/- samples at each time point. B) Average number 
of cell divisions within 72h (p=0.5240, n=4). 
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by the Osborne lab at the University of Massachusetts (Amherst, MA). These 
contain sequences encoding the active form of Notch, ICN, as well as attached 
C-terminal sequences, which code for an additional nuclear localization 
sequence (ICN.NLS) or a nuclear export sequence (ICN.NES), confining ICN to 
the nuclear or cytoplasmic compartments, respectively (Figure 41A). 
Furthermore, these ICN variants are labeled with a myc-tag for protein detection 
purposes. 
When we received the constructs they had been cloned into the pEGFP-C1 
expression vector, which encodes enhanced green fluorescent protein (eGFP) 
fused to the N-terminus of ICN. We decided to sub-clone the ICN sequences, 
without the eGFP, into our own murine stem cell virus (MSCV) retroviral vectors, 
which contain H-2Kk (H2K) sequences, for three reasons: Firstly, the fluorescent 
spectrum of eGFP interferes with that of the CFSE that will be used in our 
proliferation studies; secondly, selecting transduced cells using H2K-bead 
purification results in greater viability than sorting cells by fluorescence-activated 
cell sorting (FACS) using the eGFP-tag; thirdly and most importantly, fusion of 
the 293aa large eGFP sequence to ICN may not interfere with its localization, but 
can potentially obstruct protein-protein interactions with non-canonical binding 
partners (Shin et al. 2006).  
Unfortunately, the unique cloning sites in the polylinker, into which ICN 
sequences had been cloned, had been destroyed when generating the pEGFP- 
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Figure 41 – Generation of the ICN.NES and ICN.NLS plasmids  
A) Structure of the ICN.NES and ICN.NLS constructs. B) Schematic of the sub-
cloning strategy. 
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C1 plasmid. Therefore, a two-step cloning scheme was devised (Figure 41B). 
First, the ICN.NES and ICN.NLS sequences were excised from the pEGFP-C1 
plasmid using BspEI and SalI restriction enzymes, which create ends compatible 
with those produced upon digestion of the MSCV vector with SgrAI and XhoI, 
respectively. Ligation of the BspEI-SalI fragments containing the ICN sequences 
with the SrgAI-XhoI fragment from the MSCV vector, yielded a plasmid that 
contained sequences encoding ICN.NES or ICN.NLS and the H2K expression 
marker, but sacrificed the 5’long terminal repeat (5’LTR) important for 
transcription of the encoded sequences as well as viral insertion into the target 
genome. This preliminary construct, however, contained an EcoRI site at the 3’-
end of the subcloned ICN sequences. For the excision site at the 5’-end, a SacII 
site within the ICN sequence itself was chosen. The partial ICN.NES or ICN.NLS 
sequences were excised using SacII and EcoRI, and ligated with a fragment 
obtained from a SacII-EcoRI digestion of the MSCV-H2K-ICN vector, thereby 
restoring the lost ICN sequences at the 5’-end. Critical regions of the new 
constructs were sequenced to verify successful cloning. 
 
5.3 Verification of ICN.NES and ICN.NLS expression and functionality 
First, in order to determine if ICN.NES and ICN.NLS can be expressed, we 
retrovirally transduced these constructs into D510 T-leukemia cells that do not 
express endogenous ICN constitutively (Chari and Winandy 2008). Western blot 
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analysis using the Val1744-Ab, which recognizes ICN exclusively, detected the 
ICN.NES, but not the ICN.NLS variant (Figure 42A). Thus, ICN.NLS expression 
was tested again using a flow cytometric approach with a fluorochrome-
conjugated Notch-antibody (mN1A), which revealed that ICN.NLS is expressed 
(Figure 42B). 
Next, to test functionality of the ICN.NES and ICN.NLS proteins, expression 
levels of NTGs in D510 cells transduced with these proteins were measured 
(Figure 42C). The nuclear ICN.NLS protein is expected to increase the 
transcription of NTGs, whereas the cytoplasm-bound variant, ICN.NES, is 
excluded from direct gene transcription. As anticipated, ICN.NLS was highly 
efficient in activating transcription of NTGs that encode Deltex (dtx1), CD25 
(il2ra), pTα (ptcra) and Notch1 itself (Notch1) (Hu et al. 2008; Chari et al. 2010), 
whereas ICN.NES only slightly upregulated il2ra, validating the correct 
localization of the two ICN variants. These data demonstrate that while ICN.NLS 
acts as a robust transcriptional activator in the nucleus – presumably via the 
canonical Notch signaling pathway, which triggers NTG transcription through 
Notch activation complexes – the localization of ICN.NES outside of the nucleus 
only increased CD25 expression. Interestingly, CD25 is associated with TCR-
mediated cell activation and becomes upregulated upon T-cell stimulation. The 
IL2 signal triggers multiple signaling pathways that contribute to T-cell 
differentiation, proliferation, survival and cytokine production  
143 
 
 
 
 
Figure 42 – ICN constructs expression and function in T-cells 
D510 cells transduced with MSCV-H2K-ICN.NES or -ICN.NLS and purified with 
αH2K A) Western blot of WCE probed with αICN (clone Val1744) and αActin 
(42kDa). B) Flow cytometric histograms depicting intracellular Notch stain using 
mN1A. C) qPCR for NTGs. 
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(Malek and Castro 2010). This could suggest a role of cytoplasmic ICN in cell 
proliferation through upregulation of CD25 expression. 
 
5.4 Verification of ICN.NES and ICN.NLS localization in the CD4+ T-cell 
To verify the nuclear versus cytoplasmic localization of the newly generated 
constructs, MSCV-H2K-ICN.NES and MSCV-H2K-ICN.NLS, along with a MSCV-
H2K-ICN positive control, were retrovirally transduced into primary CD4+ T-cells. 
The transduced proteins were viewed by immunofluorescence using a 
fluorochrome-conjugated αMyc (Figure 43). Wild type ICN appeared in both the 
nucleus and cytoplasm, whereas ICN.NES localized to the cytoplasm only. 
Staining with ICN.NLS was generally weak, but did not appear in the cytoplasm 
of cells. Overall these data suggest that the constructs are correctly expressed in 
their respective subcellular compartments.  
 
5.5 Characterizing alternative, non-canonical Notch pathways 
We have demonstrated that RBPJ-mediated Notch signaling is not required 
for CD4+ T-cell proliferation and activation (Figure 38 to Figure 40). These results 
implicate RBPJ-independent, non-canonical Notch signaling pathways in the 
regulation of these functions. Therefore, we determined if Notch maintains its role 
as a transcriptional regulator utilizing DNA-binding partners other than RBPJ, or if  
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Figure 43 – ICN constructs localize to the correct subcellular compartments 
in primary T-cells 
Splenic CD4+ T-cells were isolated from spleens, activated overnight with plate-
bound αCD3/αCD28 and transduced with fresh retrovirus containing H2K-ICN, -
ICN.NES or -ICN.NLS. Cells were kept on activation stimuli for an additional 48h 
to ensure expression of retroviral proteins. Cells were analyzed by 
immunofluorescence using a fluorochrome-conjugated αMyc against the cMyc 
tag of the fusion proteins (green) and the nuclear counterstain DAPI (blue). 
Magnification for all images is 60X and scale bar represents 10μm. 
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it exhibits extra-nuclear functions interacting with signaling pathways in the 
cytosol. In this regard, we examined if the ICN variants were able to rescue T-cell 
proliferation in the presence of Notch inhibition by CompE treatment. In the first 
set of experiments, the ICN-dependent JE131 cell line was used. These cells 
were transduced with ICN.NES, ICN.NLS, a positive wild-type ICN control or a 
negative ‘empty-vector’ control, which expresses H2K surface marker, but does 
not contain an ICN insert. Successfully transduced cells were purified on the 
basis of H2K expression using magnetic beads and subsequently cultured for 
five days in the presence or absence of 2μM CompE. Cell counts were 
performed at 24h intervals (Figure 44). As expected, proliferation of cells that 
received no ICN construct (empty-vector control cells) was severely affected by 
the inhibitor, whereas that of cells transduced with wild-type ICN was rescued. 
Interestingly, both ICN.NES and ICN.NLS were also able to rescue proliferation. 
This suggests that ICN participates in pathways within the nucleus as well as the 
cytoplasm that contribute to cell proliferation.  
Next, the role of cytoplasmic versus nuclear Notch in proliferation was 
scrutinized in primary T-cells. CD4+ T-cells were activated using plate bound 
αCD3/αCD28 for 24h followed by retroviral transduction with ICN, ICN.NES, 
ICN.NLS and empty vector control. Cells were kept on activating stimulus for 
another 48h to allow incorporation and expression of the ICN proteins. A 
limitation of the retroviral transduction is the necessity for T-cell activation to  
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Figure 44 – ICN.NES and ICN.NLS rescue T-leukemia cell proliferation 
JE131 T-leukemia cells were transduced with ICN.NES, ICN.NLS, ICN wild-type 
or empty vector negative control (MSCV-Ctrl). Successfully transduced cells 
were sorted using magnetic bead-conjugated αH2K and cultured in the presence 
or absence of 2μM CompE for five days. Counts were taken at 24h intervals and 
cells were maintained at 106cells/ml with complete RPMI media containing fresh 
DMSO or CompE. ±SEM, n=3. 
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allow retroviral insertion into the genome, which is required for expression of 
transduced proteins. Cell activation results in robust Notch signaling, and T-cell 
proliferation. However, since Notch signaling is important to proliferation in the 
first 24h of TCR-stimulation (Figure 17), cells were moved off stimulation and 
rested for 24h in media alone to return them to a non-proliferative state. Rested 
cells were loaded with 5μM CFSE and reactivated for 48h in the presence or 
absence of 2μM CompE. Subsequently, cells were collected and proliferation 
profiles of successfully transduced H2K-positive cells were analyzed via flow 
cytometry (Figure 45). CompE had a clear effect on the proliferative capacities of 
the empty vector negative control transduced cells. In contrast, ICN, ICN.NES 
and ICN.NLS were capable of rescuing cell proliferation from CompE treatment.  
These preliminary data suggest that ICN may influence cell proliferation as 
a transcriptional regulator as well as from the cytosol via interactions with other 
signaling pathways.   
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Figure 45 – ICN affects proliferation from the nucleus as well as the 
cytoplasm 
Purified splenic CD4+ T-cells were activated and transduced with ICN.NES, 
ICN.NLS, ICN wild-type or empty vector negative control. After incorporation of 
the retrovirus, cells were rested for 24h to return them to a non-proliferative state. 
Cells were then loaded with 5μM CFSE, and reactivated for 48h, during which 
they were treated with or without 2μM CompE. The proliferation profile of 
successfully transduced cells was analyzed by flow cytometry. Graphs on the 
right depict the difference in population size in each division peak between 
treated and untreated cells.  
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6 DISCUSSION 
6.1 Control over Notch signal strength 
Notch signaling is essential in the development of many tissues and 
remains vital to a plethora of cellular functions in adult organisms (Andersson et 
al. 2011). In this dissertation, I have shown that Notch signaling is crucial to the 
optimal activation and proliferation of mature, peripheral CD4+ T-cells. I have also 
demonstrated that the effects of Notch signaling that influence these cellular 
functions are mediated within the first few hours of TCR-stimulation, after which 
ICN generation is being terminated. The temporal confinement of Notch signaling 
to a relatively short burst early in TCR-signaling, despite continued cell 
stimulation, may constitute a protective mechanism that controls Notch signal 
output. 
The importance of Notch signal regulation is highlighted by the emergence 
of T-ALL in T-cells with Notch mutations (Weng et al. 2004), and thus, ICN is 
tightly controlled to prevent sustained signaling at excessively high levels, or for 
inappropriately long periods of time. One way, in which this regulation is 
achieved, is through the degradation of ICN by the proteasome (Fryer et al. 
2004; Tsunematsu et al. 2004). However, proteasomal degradation only 
regulates signals that have already been created. Modifying the timing of Notch 
activation itself may be a mechanism to adjust signal output even before the 
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pathway is initiated, thus adding a layer of protection that prevents adverse 
effects such as leukemogenesis.  
A possible contributing factor in this process may be cis-inhibition through 
the upregulation of Notch ligands, which sequesters the Notch receptor and 
makes it unresponsive to activation (Sakamoto et al. 2002; Ladi et al. 2005). In 
our T-cell model, upregulation of the Notch ligand Jag2 coincided with the timing 
of ICN signal termination, suggesting that Jag2 may be partly responsible for 
limiting the time frame in which Notch can be activated. Interestingly, the gene 
encoding Jag2 has been described as a direct Myc target gene (Yustein et al. 
2010; Fiaschetti et al. 2014). The gene encoding Myc, in turn, is a direct target of 
Notch-mediated transcription (Hu et al. 2008). Hence, Notch may regulate its 
own attenuation via the transcription of myc and consequently jag2, resulting in 
cis-inhibition.  
 
6.2 Model of novel T-cell specific Notch activation 
The canonical Notch activation pathway requires ligands to induce 
conformational changes in the Notch receptor, without which receptor processing 
cannot proceed. Nevertheless, T-cells can activate Notch upon TCR-stimulation 
in the absence of such ligation (Figure 16; Palaga et al. 2003; Adler et al. 2003). 
Even though this mode of activation has been utilized to study Notch signaling, 
the underlying processes involved in this T-cell specific activation mechanism 
153 
 
remain uncharacterized. In this dissertation, I have shed light onto the unique 
system that initiates Notch processing independently of Notch ligands. 
Consequently, I propose a novel model of T-cell specific Notch activation 
proposed for the first time in this work (Figure 46).  
Signals originating from both the TCR and the CD28 co-receptor are 
indispensible for this mechanism to occur and initiate two concomitant processes 
required for successful Notch activation. In the absence of the mechanical forces 
that are generated by conventional Notch receptor ligation, the first process 
consists of internalization of the receptor and chemical adjustments in the 
endocytic compartment, which result in conformational changes in the 
autoinhibitory region of Notch and prime the receptor for cleavage. Concurrently, 
the second process activates the machinery that performs the Notch cleavage 
events. 
The latter process is induced by signals initiated by CD3 that are triggered 
by TCR-complex cross-linking. This results in the accumulation of Lck tyrosine 
kinases, which, when brought into proximity of each other, undergo trans-
autophosphorylation. Activated Lck phosphorylates ITAMs on CD3ζ-chains, 
which recruits another substrate of Lck, the tyrosine kinase ZAP-70. Activated 
ZAP-70, in turn, phosphorylates a multitude of targets, among which is PLCγ. 
This phospholipase hydrolyzes PIP2 to generate DAG, which acts as a 
membrane anchor for a variety of proteins. DAG is a crucial factor in the 
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activation of mature PKC. However, in order to undergo maturation, PKC needs 
to be phosphorylated by PDK1. Signals from the CD28 co-receptor trigger PI3K 
activation, which, through the phosphorylation of PIP2, generates another 
membrane anchor molecule, PIP3. PDK1 is recruited to the immunological 
synapse by PIP3, and can now efficiently phosphorylate and mature PKC (Pearce 
et al. 2010).  
Once mature PKC has been activated, it induces ADAM-metalloproteases, 
among which are ADAM10 and ADAM17 that are associated with Notch 
processing. ADAMs cleave the Notch receptor at the juxtamembrane S2 site, 
which subsequently allows γSec to proteolyse the receptor at the S3 site. 
However, at the cell surface, S2 is protected by the NRR autoinhibitory domain, 
which is why the internalization of the Notch receptor becomes important. The 
gradual acidification of the endocytic environment and efflux of calcium from the 
endosome (Scott and Gruenberg 2011; Tian et al. 2015) result in conformational 
changes in the Notch receptor. These changes unravel the NRR and allow 
activated ADAM-metalloproteases to initiate Notch processing, which ultimately 
results in the release of ICN.  
The requirement to prime the Notch receptor through internalization and 
changes in the endocytic environment may represent the rate-limiting step that 
causes the gradual appearance of ICN over the first few hours of cell stimulation.  
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Figure 46 – Model of novel TCR-mediated Notch activation 
Signals from the TCR-CD3 complex as well as CD28 co-receptors are needed to 
activate the Notch cleavage machinery and induce endocytosis of the Notch 
receptor.  
DAG, diacylglycerol; ICN, intracellular Notch; Lck, lymphocyte-specific protein 
tyrosine kinase; PDK1, phosphoinositide-dependent kinase-1; PI3K, 
phosphorinositide 3 kinase; PIP3, phosphatidyl-inositol 3,4,5-trisphosphate; PKC, 
protein kinase C; PLCγ, phospholipase C γ; ZAP70, zeta-chain associated 
protein kinase 70kDa; blue scissors, γSec; red scissors, ADAMs. 
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6.3 Additional mechanisms contributing to Notch activation 
Experiments with primary CD4+ T-cells demonstrate that both of the 
aforementioned processes – endocytosis and ADAM-activation – are absolutely 
required for the activation of wild-type Notch signals in peripheral T-cells. 
However, while endocytosis of the Notch receptor in leukemia cells remains a 
prerequisite even in the presence of constitutively activating Notch mutations, 
ADAM-mediated cleavage does not appear to be necessary. Despite this, in 
DO11 cells, PP1-mediated inhibition of the TCR signal attenuates the generation 
of ICN. Since ADAM-mediated cleavage is superfluous in these cells, this implies 
a second set of signals originating from the TCR that are important in Notch 
activation and may be involved in internalization processes. For instance, 
endocytosis of the Notch receptor could be facilitated by TCR-induced mono-
ubiquitination events (Gupta-Rossi et al. 2004). It will be interesting to determine 
the mechanics of this second set of signals in both primary cells and cell lines.  
Furthermore, since ADAM-dependent pathways of Notch activation are 
obsolete in the leukemia cells, further investigation needs to be conducted to 
elucidate how the Notch receptor is processed in this setting. One possibility is 
that mutations in the HD region of Notch – whether these are hot spot or yet 
unknown mutations – destabilize the NRR to such a degree that even the 
smallest environmental changes in the endosome are sufficient to result in 
Notch-ECD shedding, allowing for γSec-mediated release of ICN. Since 
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chloroquine was only moderately able to terminate ICN generation in primary 
CD4+ T-cells, an attenuated acidic environment may be sufficient to enable 
proficient Notch processing in DO11 cells. However, it remains to be determined 
if this is the case or if an entirely separate mechanism is involved.   
Lastly, activation experiments of CD4+ T-cells with PMA and ionomycin 
indicate that there are additional signals triggered by the TCR that effect Notch 
activation. In CD4+ T-cells, activation with PMA alone is sufficient to induce 
robust ICN generation. This is due to the fact that PMA is a strong inducer of 
PKC activity (van Tetering et al. 2009; Mochly-Rosen et al. 2012). However, 
activation with a combination of PMA and ionomycin results in a synergistic effect 
on ICN production, suggesting that Ca2+ flux, regulated by ionomycin, may 
enhance Notch activation. A possible pathway through which Ca2+ may facilitate 
Notch processing is via the augmentation of PKC activity, since a subset of PKC 
isoforms requires Ca2+ in addition to DAG-binding for optimal activation (Baier 
and Wagner 2009). Even so, the exact mechanisms of how Ca2+ enhances these 
processes are subject to further investigation. 
Going forward, the focus of this part of the project should be to examine the 
possible mechanisms described above, as well as define the endocytic 
machinery that facilitates Notch receptor endocytosis. Having established that 
receptor internalization is a prerequisite in the activation of Notch in our cell lines, 
this provides us with an excellent tool to study these events. Cell lines can easily 
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be manipulated and transfected with siRNAs against various components 
involved in endocytosis, which will assist in the analysis of this process. 
Ultimately, TCR-mediated Notch endocytosis could be targeted in T-ALL to 
specifically inhibit receptor activation in T-cells, without affecting other Notch 
signals in surrounding cells. 
 
6.4 The value of a TCR-mediated Notch activation mechanism 
The utility of this unique TCR-mediated mode of Notch activation may have 
its origins in the fact that T-cells are part of a fluid system of migrating cells. 
Generally, the Notch receptor decides cell fates in solid tissues, in which lateral 
interactions can be sustained indefinitely. In contrast, T-cells spend some of their 
life cycle in circulation or percolating through secondary lymphoid organs on the 
search for cognate antigen (Krummel et al. 2016). Since the Notch pathway does 
not contain an inherent amplification cascade that would enhance external stimuli 
– Notch signal input creates a stoichiometric signal output – the one-to-one 
interaction of ligand on antigen presenting cells with Notch receptor on T-cells, as 
well as the short half-life of ICN, may not result in sufficient Notch signal to 
robustly activate a full program of Notch target gene activation. TCR-signaling, 
which itself does undergo multiple rounds of signal amplification, may serve to 
circumvent this deficiency and activate adequate levels of Notch signal when a 
cognate antigen has been recognized. Since Notch signaling optimizes T-cell 
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responses, such as proliferation and activation, the T-cell is not reliant on 
additional Notch ligands and can autonomously couple Notch activation to TCR-
stimulation.  
  
6.5 Non-canonical Notch signaling in T-cells 
It is becoming increasingly recognized that RBPJ-dependent signaling is 
not the only pathway that Notch utilizes to transduce its signal. A growing number 
of studies are proposing interactions with other cytosolic and nuclear binding-
partners including mTORC2/PI3K/Akt (Sade et al. 2004; Perumalsamy et al. 
2009 and 2012) and NFκB (Shin et al. 2006 and 2014). These interactions 
contribute to the regulation of functions such as cell cycle control, metabolism 
and differentiation.  
Our results have demonstrated that T-cell activation and proliferation are 
regulated by Notch pathways that are independent of RBPJ. Interestingly, 
preliminary results using two retroviral ICN-constructs that are restricted to either 
the nucleus or the cytoplasm, suggest that these non-canonical functions of 
Notch are localized to both of the subcellular compartments. Using these 
constructs, it will be important to further elucidate which signaling pathways 
Notch engages to regulate activation and proliferation of T-cells. Co-localization 
assays via fluorescent microscopy or immunoprecipitation may be utilized to 
determine physical contact between Notch and components of other signaling 
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pathways. Another fascinating question that needs to be answered is how ICN 
influences signal patterns of other molecules. Because of its lack of catalytic 
domains, it may be possible that ICN regulates trafficking to specific subcellular 
compartments or promotes retention at certain sites, such as promoter regions. 
Overall, with the emergence of non-canonical signaling pathways an entirely new 
and exciting field in Notch research has been accessed.  
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